EP0566427A2 - A prothesis and a method of making the same - Google Patents

A prothesis and a method of making the same Download PDF

Info

Publication number
EP0566427A2
EP0566427A2 EP93302969A EP93302969A EP0566427A2 EP 0566427 A2 EP0566427 A2 EP 0566427A2 EP 93302969 A EP93302969 A EP 93302969A EP 93302969 A EP93302969 A EP 93302969A EP 0566427 A2 EP0566427 A2 EP 0566427A2
Authority
EP
European Patent Office
Prior art keywords
prosthesis
lamination component
porous lamination
holes
porous
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
EP93302969A
Other languages
German (de)
French (fr)
Other versions
EP0566427B1 (en
EP0566427A3 (en
Inventor
Schoici Kyocera Corp Kyoto Karasuma Of Hamamoto
Hirokazu c/o Kyocera Corporation Mitsui Amino
Noriyuki c/o Kyocera Corporation Mitsui Ishida
Yasunori C/O Kyocera Corporation Tamura
Yoichi c/o Kyocera Corp. Mitsui Seimei Nishio
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Kyocera Corp
Original Assignee
Kyocera Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kyocera Corp filed Critical Kyocera Corp
Publication of EP0566427A2 publication Critical patent/EP0566427A2/en
Publication of EP0566427A3 publication Critical patent/EP0566427A3/en
Application granted granted Critical
Publication of EP0566427B1 publication Critical patent/EP0566427B1/en
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Images

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/02Prostheses implantable into the body
    • A61F2/30Joints
    • A61F2/30767Special external or bone-contacting surface, e.g. coating for improving bone ingrowth
    • A61F2/30907Nets or sleeves applied to surface of prostheses or in cement
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61CDENTISTRY; APPARATUS OR METHODS FOR ORAL OR DENTAL HYGIENE
    • A61C8/00Means to be fixed to the jaw-bone for consolidating natural teeth or for fixing dental prostheses thereon; Dental implants; Implanting tools
    • A61C8/0012Means to be fixed to the jaw-bone for consolidating natural teeth or for fixing dental prostheses thereon; Dental implants; Implanting tools characterised by the material or composition, e.g. ceramics, surface layer, metal alloy
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/02Prostheses implantable into the body
    • A61F2/28Bones
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/02Prostheses implantable into the body
    • A61F2/30Joints
    • A61F2/30721Accessories
    • A61F2/30734Modular inserts, sleeves or augments, e.g. placed on proximal part of stem for fixation purposes or wedges for bridging a bone defect
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/02Prostheses implantable into the body
    • A61F2/30Joints
    • A61F2/32Joints for the hip
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/02Prostheses implantable into the body
    • A61F2/30Joints
    • A61F2/44Joints for the spine, e.g. vertebrae, spinal discs
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/02Inorganic materials
    • A61L27/04Metals or alloys
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/50Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • A61L27/56Porous materials, e.g. foams or sponges
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/02Prostheses implantable into the body
    • A61F2/30Joints
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/02Prostheses implantable into the body
    • A61F2/30Joints
    • A61F2/30767Special external or bone-contacting surface, e.g. coating for improving bone ingrowth
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/02Prostheses implantable into the body
    • A61F2/30Joints
    • A61F2/3094Designing or manufacturing processes
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/02Prostheses implantable into the body
    • A61F2/30Joints
    • A61F2/32Joints for the hip
    • A61F2/34Acetabular cups
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/02Prostheses implantable into the body
    • A61F2/30Joints
    • A61F2/32Joints for the hip
    • A61F2/36Femoral heads ; Femoral endoprostheses
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/02Prostheses implantable into the body
    • A61F2/30Joints
    • A61F2/32Joints for the hip
    • A61F2/36Femoral heads ; Femoral endoprostheses
    • A61F2/3662Femoral shafts
    • A61F2/367Proximal or metaphyseal parts of shafts
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/02Prostheses implantable into the body
    • A61F2/30Joints
    • A61F2002/30001Additional features of subject-matter classified in A61F2/28, A61F2/30 and subgroups thereof
    • A61F2002/30108Shapes
    • A61F2002/3011Cross-sections or two-dimensional shapes
    • A61F2002/30112Rounded shapes, e.g. with rounded corners
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/02Prostheses implantable into the body
    • A61F2/30Joints
    • A61F2002/30001Additional features of subject-matter classified in A61F2/28, A61F2/30 and subgroups thereof
    • A61F2002/30108Shapes
    • A61F2002/3011Cross-sections or two-dimensional shapes
    • A61F2002/30138Convex polygonal shapes
    • A61F2002/30158Convex polygonal shapes trapezoidal
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/02Prostheses implantable into the body
    • A61F2/30Joints
    • A61F2002/30001Additional features of subject-matter classified in A61F2/28, A61F2/30 and subgroups thereof
    • A61F2002/30108Shapes
    • A61F2002/30199Three-dimensional shapes
    • A61F2002/30261Three-dimensional shapes parallelepipedal
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/02Prostheses implantable into the body
    • A61F2/30Joints
    • A61F2002/30001Additional features of subject-matter classified in A61F2/28, A61F2/30 and subgroups thereof
    • A61F2002/30316The prosthesis having different structural features at different locations within the same prosthesis; Connections between prosthetic parts; Special structural features of bone or joint prostheses not otherwise provided for
    • A61F2002/30329Connections or couplings between prosthetic parts, e.g. between modular parts; Connecting elements
    • A61F2002/30433Connections or couplings between prosthetic parts, e.g. between modular parts; Connecting elements using additional screws, bolts, dowels, rivets or washers e.g. connecting screws
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/02Prostheses implantable into the body
    • A61F2/30Joints
    • A61F2/30767Special external or bone-contacting surface, e.g. coating for improving bone ingrowth
    • A61F2/30771Special external or bone-contacting surface, e.g. coating for improving bone ingrowth applied in original prostheses, e.g. holes or grooves
    • A61F2002/30772Apertures or holes, e.g. of circular cross section
    • A61F2002/30784Plurality of holes
    • A61F2002/30785Plurality of holes parallel
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/02Prostheses implantable into the body
    • A61F2/30Joints
    • A61F2/30767Special external or bone-contacting surface, e.g. coating for improving bone ingrowth
    • A61F2/30907Nets or sleeves applied to surface of prostheses or in cement
    • A61F2002/30909Nets
    • A61F2002/30911Nets having a honeycomb structure
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/02Prostheses implantable into the body
    • A61F2/30Joints
    • A61F2/30767Special external or bone-contacting surface, e.g. coating for improving bone ingrowth
    • A61F2/30907Nets or sleeves applied to surface of prostheses or in cement
    • A61F2002/30909Nets
    • A61F2002/30915Nets made of a stack of bonded perforated sheets, grids or wire meshes
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/02Prostheses implantable into the body
    • A61F2/30Joints
    • A61F2/30767Special external or bone-contacting surface, e.g. coating for improving bone ingrowth
    • A61F2002/30929Special external or bone-contacting surface, e.g. coating for improving bone ingrowth having at least two superposed coatings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/02Prostheses implantable into the body
    • A61F2/30Joints
    • A61F2/3094Designing or manufacturing processes
    • A61F2002/30971Laminates, i.e. layered products
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/02Prostheses implantable into the body
    • A61F2/30Joints
    • A61F2/32Joints for the hip
    • A61F2/36Femoral heads ; Femoral endoprostheses
    • A61F2/3601Femoral heads ; Femoral endoprostheses for replacing only the epiphyseal or metaphyseal parts of the femur, e.g. endoprosthetic femoral heads or necks directly fixed to the natural femur by internal fixation devices
    • A61F2/3603Femoral heads ; Femoral endoprostheses for replacing only the epiphyseal or metaphyseal parts of the femur, e.g. endoprosthetic femoral heads or necks directly fixed to the natural femur by internal fixation devices implanted without ablation of the whole natural femoral head
    • A61F2002/3605Femoral heads ; Femoral endoprostheses for replacing only the epiphyseal or metaphyseal parts of the femur, e.g. endoprosthetic femoral heads or necks directly fixed to the natural femur by internal fixation devices implanted without ablation of the whole natural femoral head made of two or more concentric caps fitted onto one another
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2220/00Fixations or connections for prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
    • A61F2220/0025Connections or couplings between prosthetic parts, e.g. between modular parts; Connecting elements
    • A61F2220/0041Connections or couplings between prosthetic parts, e.g. between modular parts; Connecting elements using additional screws, bolts, dowels or rivets, e.g. connecting screws
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2230/00Geometry of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
    • A61F2230/0002Two-dimensional shapes, e.g. cross-sections
    • A61F2230/0004Rounded shapes, e.g. with rounded corners
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2230/00Geometry of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
    • A61F2230/0002Two-dimensional shapes, e.g. cross-sections
    • A61F2230/0017Angular shapes
    • A61F2230/0026Angular shapes trapezoidal
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2230/00Geometry of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
    • A61F2230/0063Three-dimensional shapes
    • A61F2230/0082Three-dimensional shapes parallelepipedal
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2310/00Prostheses classified in A61F2/28 or A61F2/30 - A61F2/44 being constructed from or coated with a particular material
    • A61F2310/00005The prosthesis being constructed from a particular material
    • A61F2310/00011Metals or alloys
    • A61F2310/00017Iron- or Fe-based alloys, e.g. stainless steel
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2310/00Prostheses classified in A61F2/28 or A61F2/30 - A61F2/44 being constructed from or coated with a particular material
    • A61F2310/00005The prosthesis being constructed from a particular material
    • A61F2310/00011Metals or alloys
    • A61F2310/00023Titanium or titanium-based alloys, e.g. Ti-Ni alloys
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2310/00Prostheses classified in A61F2/28 or A61F2/30 - A61F2/44 being constructed from or coated with a particular material
    • A61F2310/00005The prosthesis being constructed from a particular material
    • A61F2310/00011Metals or alloys
    • A61F2310/00029Cobalt-based alloys, e.g. Co-Cr alloys or Vitallium
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2310/00Prostheses classified in A61F2/28 or A61F2/30 - A61F2/44 being constructed from or coated with a particular material
    • A61F2310/00389The prosthesis being coated or covered with a particular material
    • A61F2310/00592Coating or prosthesis-covering structure made of ceramics or of ceramic-like compounds
    • A61F2310/00796Coating or prosthesis-covering structure made of a phosphorus-containing compound, e.g. hydroxy(l)apatite

Definitions

  • the present invention relates to a prosthesis for the replacement of hard tissues such as human bones or joints having significantly deteriorated or lost functions thereof, and more particularly to a prosthesis having a porous surface structure capable of allowing bone tissues to penetrate so that the support/fixture characteristics of the joining section between the prosthesis and the living tissues can be enhanced.
  • the present invention also relates to a method of making such a prosthesis.
  • the above-mentioned prostheses have the following problems.
  • the prosthesis (1) has a low volume porosity (the ratio of the volume on pores to the entire volume of the porous component thereof); it is generally said that the typical volume porosity of the above-mentioned conventional prostheses is about 35%.
  • this volume porosity is low, the relative volume of the bone tissue is small even if the bone tissue completely fills up all pores. Accordingly, the strength of the bonding between the prosthesis and the bone joined thereto is not sufficiently large.
  • the mechanical strength of the prosthesis' base material is significantly lowered by high temperature in the sintering process wherein the beads are attached.
  • the fatigue strength of such a prosthesis is lowered to about 1/5 on that of the base material.
  • the sintering process thus significantly adversely affects the durability of the prosthesis when used in the living tissue.
  • the bonding strength obtained among the above-mentioned beads is low, the beads may drop after sintering and may be in danger of penetrating articulation surfaces.
  • the volume porosity of the porous lamination component thereof is about 50% and the fatigue strength of the porous lamination component is about 70% of the base material thereof, showing a considerable improvement when compared with the above-mentioned prosthesis (1). It is however difficult to control the size and shape of small through holes within desired ranges in the compression process. As a result, the size and shape on the small through holes to be formed are not best suited for the penetration and ingrowth of the bone tissue. Furthermore, the above-mentioned porous lamination component has a disadvantage of generating a great difference in the size and shape on the through holes between those formed in the flat surfaces and those formed in the curved surfaces of the prosthesis because of the difference in the compression load. This changes the degree of the penetration of the bone tissue into the small through holes depending on the portion of the prosthesis, and causes the problem of generating different strength of the bonding between the porous lamination component and the bone to be joined depending on the portion of the prosthesis.
  • the above-mentioned prosthesis (4) has a surface structure having through holes with a diameter of about 300 f..lm disposed regularly.
  • the through holes however are not open pores communicating with one another but closed pores, thereby preventing bio-liquid from flowing among bone cells, causing the problem of necrosis at the leading ends on the bone cells.
  • the porous lamination component thereof is made by casting, it is difficult to apply the porous lamination component to portions having complicated curved surfaces. Furthermore, the production cost is high because casting is used.
  • the above-mentioned prosthesis (6) has a surface structure similar to that of a cancellous bone in size and shape.
  • the size and shape of the through holes in this structure are, however, not best suited for the penetration of bone tissues, thereby causing the problem on preventing bone tissues from sufficiently penetrating the through holes.
  • the porous lamination component thereof cannot be used for complicated curved surfaces or small- diameter cylindrical surfaces. Furthermore, the shape and arrangement on the holes are significantly deformed and dislocated by lamination and compression. It is therefore difficult to properly control the through hole shape best suited for the penetration of bone tissues, thereby causing the problem of preventing bone tissues from sufficiently penetrating the through holes.
  • the object of the present invention is to provide a prosthesis for the replacement of hard tissues of human bones or joints, comprising a porous lamination component of metallic thin sheets, each having a plurality of through holes and a thickness of 150 ⁇ m or less and being unharmful to the living body, or a prosthesis which is partially composed of the above-mentioned porous lamination component at a desired surface portion on the prosthesis base.
  • the term "base” here implies a portion to be embedded in the living bone tissue (hereinafter only referred to as "base”).
  • Another object of the present invention is to provide a method on making such a prosthesis.
  • porous thin sheets 1, 2,... each having a thickness of 150 ⁇ m or less, are laminated and formed in a desired prosthesis shape, or laminated on the flat or curved surface of a prosthesis base.
  • small through holes H having a shape suited nor the penetration and ingrowth of a plurality of bone cells are provided.
  • a prosthesis surface having a porous lamination component S1 with a three-dimensional cubic structure is formed by slightly displacing the positions of the through holes disposed in laminated thin sheets in the direction of the depth.
  • the bone tissues penetrated and grown in the three-dimensional space inside the porous surface functions to firmly support the prosthesis in the living body by utilizing its cubic structure, thereby preventing the micro-movement of the prosthesis. Furthermore, by coating a bio-compatible material, in which bone cells can easily grow, on the laminated thin sheets, the penetration of bone cells can be promoted more promptly after the replacement operation of the prosthesis, thereby permitting earlier fixture to the bone to be joined. Moreover, when a prosthesis made by laminating the thin sheets 1,2,... having through holes H with an effective diameter of 100 to 400 ⁇ m is secured with bone cement, the fixture performance between the bone cement and the prosthesis can be enhanced significantly.
  • Fig. 1 is a perspective view of a porous lamination component S1 comprising the whole of a prosthesis, or a part or the whole of the base surface of a prosthesis of the present invention.
  • the porous lamination component S1 measures 10 x 15 x 2 mm. It has a sequentially laminated structure including 20 layers of porous thin sheets 1, 2,..., each having a thickness of 100 ⁇ m and a plurality of through holes.
  • the thin sheets 1, 2,... are made of pure titanium. After the thin sheets 1, 2,... were positioned properly while being laminated, and secured temporarily by placing a very light weight on them or by using adhesive, they were heated at about 900°C in a vacuum sintering furnace so that they were bonded mutually.
  • the heater of the sintering furnace is made on molybdenum.
  • the heating process can be conducted in an atmosphere of inert gas such as argon.
  • the bonding on the thin sheets 1, 2,... was conducted by diffusion-bonding between metal atoms.
  • the thin sheets 1,2,... were positioned by utilizing the rectangular sides thereof as reference sides. In the process inside the vacuum furnace, although the overlap on the through holes H may be dislocated slightly, the amount on the dislocation is about 20 f..lm and is almost negligible nor proper production.
  • positioning holes should preferably be provided at the four corners of the thin sheets 1, 2,... Afterthe thin sheets 1,2,...were diffusion-bonded mutually in this way, no special change was recognized in the appearance and dimensions on the porous lamination component S1 and no deteriorated layer was recognized.
  • Fig. 2 shows a magnified view of regular hexagonal through holes H formed in the thin sheets 1, 2, 3,4,... of the above-mentioned porous lamination component S1.
  • the shape of the regular hexagonal through holes H is one of shapes suited for easy penetration and dense ingrowth of osteon, the minimum unit of bone tissues.
  • the shape is also suited for allowing the highest density filling arrangement on the through holes.in the same way as that shown in honeycombs and crystal structures.
  • the diameter of the inscribed circle on the through hole H of this example was determined to be about 350 ⁇ m. Since the etching method as described below was used to form the through holes H in this example, the central sectional portion of the through hole H was raised.
  • the diameter of the inscribed circle at the mostly raised portion became about 300 ⁇ m.
  • the space t between the through holes H resulted in 150 ⁇ m.
  • the volume porosity of the pores in the porous lamination component S1 designed in this way is about 50% per unit volume, that is, the volume porosity of the porous lamination component S1 is 50%.
  • the volume porosity of the porous lamination component S1 can be easily controlled by appropriately adjusting the effective diameter of the through holes H, the interval between the through holes H and the combination of lamination layers.
  • the volume porosity can be changed to about 60%.
  • the volume porosity can be changed to about 75%.
  • the volume porosity should preferably be as large as possible to make the amount of bone tissues to penetrate as much as possible.
  • the above-mentioned through holes H were formed by an etching method.
  • the through holes H can also be formed by laser processing or punching.
  • Fig. 3 is a sectional view of the porous lamination component S1 taken on line I-I of Fig. 1.
  • the through hole H disposed at the n-th line and the m-th column of the first layer is defined to be represented as 1Hnm.
  • the through hole H represented by 1H11 is a through hole disposed at the first line and the first column of the first layer.
  • the thin sheets 1, 2,... with a thickness of 100 ⁇ m are laminated and the through holes 1 H11 and 2H11 communicate with each other.
  • the layers of the porous lamination component S1 are often dislocated slightly as described above.
  • the cross section of the sheet has a shape similarto a rhombus because of the projection section projecting toward the center of the through hole H as shown in the figure, and the angle of the inclined surface thereof is in the range of about 30 to 45 degrees.
  • the cross section of the sheet has a shape similar to an isosceles triangle. Whether the thin sheet is etched on both sides or on one side is determined by considering the shape of the prosthesis to be used and the biomechanical conditions at the hard tissue portion to be replaced. More particularly, it is necessary to consider what kind of stress and how much stress remains on the surface of the porous lamination component S1.
  • the porous lamination component S1 should be designed so that bone cement can easily penetrate the through holes H and cannot come out easily after polymerization.
  • the porous lamination component S1 processed as described above has slight dislocations at laminated portions.
  • the positions of the through holes 1 H11 and 2H11 are dislocated slightly from their designed positions. If the through holes H in the thin sheets 1, 2,... are designed to be disposed alternately as shown in Fig. 4, more spaces can be provided to guide bone tissues. With this structure, bone tissues can penetrate the prosthesis for an extended period of time, thereby being more effective for the support of the prosthesis.
  • This kind of uniform plan view shape and three-dimensional structure of the through holes H can be formed on any prosthesis surfaces by utilizing the present invention.
  • the plan view shape of the through holes H should preferably be a regular hexagonal shape having the highest density filling efficiency, and should also be a shape capable of increasing the volume porosity as large as possible.
  • the through holes H adjacent to one another should preferably have open three-dimensional structures contacting one another.
  • the through holes H should preferably be coated with a bio-active living body material having affinity to bone tissues.
  • bioglass ceramics, chitin, chitosan and gelatin can be nominated.
  • titanium oxide coating or titanium nitride coating superior in corrosion resistance in the living body should preferably be used to prevent metal ions from flowing out.
  • the through holes H should preferably be coated with an agent, such as a silane coupling agent, which can strengthen the force of adhesion to bone cement.
  • Figs. 5, and 7 show various plan view shapes of the through holes H.
  • the plan view shapes of the through holes H should be suited for the penetration of bone cells.
  • Fig. 5 shows the through holes H disposed at the highest density arrangement.
  • Fig. 6 shows the through holes H with various diameters.
  • a plan view shape having distributed pores with various diameters in a constant area such as that shown in Fig. 6, can also be considered to be effective.
  • This kind of plan view shape can also be obtained easily by utilizing the present invention.
  • indeterminate forms of through holes H shown in Fig. 7 may be desirable.
  • a proper response may not necessarily be obtained by circular through holes, but a tapered shape may be preferable.
  • Figs. 8, 9 and 10 show the sectional structures on the through holes H in the laminated thin sheets 1, 2,...
  • Fig. 8 shows a sectional structure wherein the effective dimensions of the through holes H disposed in the thin sheets 1, 2,... become smaller as the through holes H are disposed closer to the prosthesis base I from the bone tissue side B.
  • Fig. 9 shows a sectional structure which is opposite to that shown in Fig. 8. This sectional structure is particularly effective when a tension load is applied to the porous lamination component surface.
  • Fig. 10 shows a sectional structure wherein the areas on the through holes H in the second and fourth layers are especially larger than those of the through holes in the other layers.
  • the positional relationship among the thin sheets are dislocated slightly.
  • the dislocation can be neglected to some extent by using the structure shown in Fig. 10.
  • the structure wherein the diameters of the through holes H are made larger in the upward or downward direction is suited for the ingrowth of bone tissues.
  • Fig. 11 shows a schema illustrating the porous lamination component S1 made as described above and used for an animal experiment to examine the effectiveness thereof.
  • the porous lamination component S1 used for this experiment has through holes H which pass through straight in the vertical direction as shown in Fig. 3.
  • the effective diameter of the through hole H is 350 f..lm and the volume porosity of the porous lamination component S1 is 60%.
  • JBMR Journal of Biomedical Materials Research
  • the porous lamination component S1 was cleansed, autoclaved, and wetted with a saline solution including a dissolved antibiotic.
  • the porous lamination component S1 was then embedded into a gutter by pounding it with a hammer.
  • the periosteum, muscle, fascia and skin were stitched up together in accordance with the conventional methods. After the antibiotic was given, the treatment portion was laid quietly. Each rabbit was allowed to move freely in a cage (50 x 80 x 40 cm) and was fed with solid food and water.
  • the rabbits were killed four and six weeks after operation. As shown in Fig. 12, the porous lamination component S1 and a part of the tibia T around the porous lamination component were taken out. After about two hours, without formalin fixation, a wire W was passed through the tibia T as shown in Fig. 13 and the adhesion strength D of the structure was measured by using an instron testing machine. The loading condition of the instron testing machine was given at a cross head speed of 3.5 cm/min in accordance with the above-mentioned method.
  • Fig. 14 is a graph illustrating the measurement results of the adhesion strength D.
  • the points marked 0 indicate the adhesion strength of the porous lamination component S1 of the present invention.
  • the adhesion strength of the porous lamination component S1 was about 10 kg five weeks after adhesion. After ten weeks, the adhesion strength of the S1 was about 12 kg.
  • the adhesion strength per unit area was 6 kg/cm 2 after five weeks and 8 kg/cm 2 after ten weeks. Breakage occurred in the tibia T attached to the porous lamination component S1. No separation was observed at the interfaces of the thin sheets of the porous lamination component S1.
  • the points marked o indicate the adhesion strength of the bioglass ceramics reported in the above-mentioned literature.
  • the porous lamination component S1 of the present invention is superior to the bioglass ceramics and hydroxyapatite, which are assumed to be the most bio-active materials among the currently available living body materials in terms of the performance of bonding and adhesion to bone tissues. It is also found that the adhesion strength of the prosthesis reaches a value almost similar to the strength of the bone in a short period of about ten weeks.
  • Figs. 15, 16 and 17 are microphotographs illustrating the histopathological examination results of the porous lamination component S1 used for the adhesion strength measurement tests.
  • the bone tissues obtained afterthe adhesion strength tests and the porous lamination component S1 were subjected to dehydration and resin embedding in accordance with the conventional methods, and sliced in the direction perpendicular to the longitudinal axis of the tibia T, then manually processed to obtain ground sections Z with a thickness of up to about 50 ⁇ m.
  • the sections were observed by using a light microscope in accordance with the normal light microscopy method and the fluorescent microscopy method.
  • Fig. 15 is a microphotograph at 5500 magnifications. It is found that bone tissue A and marrow tissue B coexist in the through holes H in the regions of the thin sheets 1 to 5. In addition, blood vessel tissues and new osteoblasts were observed with the naked eye, although they were not taken clearly on the microphotograph.
  • Fig. 16 shows a fluorescent microscopic image of the image shown in Fig. 15.
  • Fig. 17 shows the regions corresponding to the thin sheets 11 to 15. Although the amount of the bone tissue A is smaller, there are no great differences in the calcification degree and the adhesion strength of the bone tissue.
  • the bone tissue A penetrated almost all through holes H of the thin sheets 1 to 20 of the porous lamination component S1 grew in the through holes. It is found that the tissue A is a normal bone tissue including marrow tissue B. This result indicates that a complex substance is formed between the surface of the porous lamination component of the present invention and the bone and that the metallic thin sheets reinforce the bone tissues. In addition, it is found that the bonding strength of the porous lamination component S1 is sufficient and that the force of adhesion to the bone is almost equal to the breakage force of the bone itself.
  • the adhesion strength is 12 kg/cm 2 . This value is almost equal to the strength of the bone as described above. It was confirmed that a breakage occurred at the tibia T. On the other hand, when the thickness is larger than 150 ⁇ m, the adhesion strength is less than 10 kg/cm 2 . In this case, it was also confirmed that a breakage occurred in the porous lamination component S1.
  • the thickness is larger than 150 ⁇ m, the amount of the projection at the projection portions h is large, and the diameter of the through holes H in the direction of the thickness is reduced to about 10 ⁇ m, thereby assumably resulting in the breakage of the bone tissues at the region of the reduced diameter portions.
  • the thickness is smaller than 10 ⁇ m, the number of the thin sheets 1, 2,... to be laminated increases significantly. This makes the production of the porous lamination component extremely difficult.
  • the adhesion strength is 12 kg/cm 2 . This value is almost equal to the strength of the bone as described above. It was confirmed that a breakage occurred at the tibia T. On the other hand, when the thickness is smaller than 10 ⁇ m or larger than 150 ⁇ m, the adhesion strength is less than 10 kg/cm 2 . In this case, it was confirmed that a breakage occurred in the porous lamination component S1.
  • porous lamination component S1 comprising thin sheets 1, 2,... having a thickness of 100 ⁇ m and the through holes H with an effective diameter of 300 ⁇ m and also having different volume porosity values listed in Table 4 were made in accordance with the above-mentioned method.
  • the cross sectional structure of the porous lamination component S1 had the through holes H alternately disposed in the thin sheets 1, 2,... as shown in Fig. 4.
  • the adhesion strength is 12 kg/cm 2 . This value is almost equal to the strength of the bone as described above. It was confirmed that a breakage occurred at the tibia T. On the other hand, when the volume porosity is less than 45%, the adhesion strength is less than 10 kg/cm 2 . In this case, it was confirmed that a breakage occurred in the porous lamination component S1.
  • the preferable thickness of the thin sheets 1,2,... is 150 ⁇ m or less, more particularly in the range of 10 to 150 ⁇ m, the preferable effective hole diameter is in the range of 100 to 400 ⁇ m and the preferable volume porosity of the porous lamination component S1 is 45% or more.
  • Fig. 18 shows an artificial vertebral body AL used as a prosthesis of an example on the present invention.
  • Ten pieces of 100 ⁇ m thick titanium thin sheets 1, 2,... having the same shape as that on the end surface of the artificial vertebral body AL were laminated to form a porous lamination component AL2 having a thickness of about 1 mm and this porous lamination component AL2 was bonded to both ends of the cubic artificial vertebral bodyALmade of a titanium alloy.
  • the effective diameterof the through holes H was 300 ⁇ m.
  • Other design items were the same as those of the example 1.
  • the artificial vertebral main body AL1 laminated with the porous lamination component AL2 comprising the lamination of the above-mentioned thin sheets 1, 2,... as shown in Fig. 18 was heated up to about 900°C in a vacuum furnace in an atmosphere of inert gas (argon).
  • the surfaces of the artificial vertebral body AL were then coated with hydroxyapatite by flame spray coating.
  • the hydroxyapatite was converted into a paste state, and recrystallized by heat treatment.
  • Bioglass ceramics was then used for coating.
  • an artificial vertebral body AL was made as described below.
  • both ends of the artificial vertebral main body AL1 were coated with hydroxyapatite, and the porous lamination components AL2 were laminated on the artificial vertebral main body AL1 and then these laminated components were heated in the vacuum furnace as described above. Hydroxyapatite was coated only on the internal wall surfaces of the through holes H disposed close to the interfaces between the porous lamination components AL2 and the artificial vertebral main body AL1.
  • hydroxyapatite coating was performed by flame spray coating on one end of the porous lamination component AL2 which had been made previously in accordance with the method used for example 1.
  • an artificial vertebral body AL in which the internal wall surfaces of the through holes H were coated with hydroxyapatite only on the intermediate layers of the porous lamination component AL2, was obtained.
  • the coating range in the cross section of the porous lamination component can be controlled.
  • Fig. 19 is a side view illustrating the condition wherein a lumbar vertebra LB and an intervertebral disk LD are replaced with the above-mentioned artificial vertebral body AL.
  • this example can be applied to various prostheses such as spinous process spacers, iliac bone spacers, posterior cranial fossa plates and artificial knee joint tibial components.
  • Fig. 20 is a perspective view illustrating an artificial dental root AR of the present invention.
  • the artificial dental root AR comprises a cylindrical artificial dental root body AR1 and an artificial dental root porous lamination component AR2 formed around the cylindrical surface of the artificial dental root body AR1.
  • Fig. 21 is a plan view of a thin sheet AR4 which is used to form the artificial dental root porous lamination component AR2.
  • the thin sheet AR4 has a shape of band measuring 50 ⁇ m in thickness, 7.9 mm in width and 1000 mm in length. It has a plurality of through holes H with an effective diameter of about 300 f..lm, with non-pore fringe portions AR5 having a horizontal width of about 1 mm provided around the external fringe of the band. Furthermore, at the leading end of the above-mentioned thin sheetAR4, two fixture holes AR6 are provided.
  • Fig. 22 is a sectional view illustrating a method of laminating the band-shaped artificial dental root porous lamination componentAR2 overthe porous lamination component accommodation section AR9 of the artificial dental root body AR1.
  • the artificial dental root body AR1 was secured at the axial center thereof.
  • Two 0.85 mm diameter titanium rods AR11 were respectively driven into the two thin sheet fixture holes AR10 disposed in the porous lamination component accommodation section AR9 of the artificial dental root body AR1 shown in Fig. 23.
  • the above-mentioned fixture holes AR6 disposed in the thin sheet AR4 were fitted over the rods AR11.
  • the projected portions of the rods AR11 were then removed by filing operation. After this, while the thin sheet AR4 was pulled to prevent it from being deflected, the artificial dental root body AR1 was rotated to wind the thin sheet AR4 around the artificial dental root body AR1.
  • the thickness of the thin sheet AR4 was 50 f..lm
  • the thickness of the artificial dental root porous lamination component AR2 was equal to the depth of the above-mentioned porous lamination component accommodation section, i. e., 1 mm after the thin sheet AR4 was rotated about 20 times.
  • the thin sheet AR4 was then cut at an appropriate position, the trailing end thereof was temporarily secured by using adhesive and heated at about 900°C in the vacuum furnace.
  • Fig. 23 is a side view of the artificial dental root body AR1.
  • the artificial dental root body AR1 is a cylinder with an overall length of 12 mm and comprises a 4 mm diameter end section AR7 disposed at one end thereof, a leading end section AR6 disposed at the other end thereof and having a round end, and the porous lamination component accommodation section AR9 disposed between the end section AR7 and the leading end section AR6 and having a length of about 8 mm and a diameter of 3 mm.
  • the porous lamination component accommodation section AR9 is provided with two thin sheet fixture holes AR10 with a diameter of 0.8 mm in the porous lamination component accommodation section AR9.
  • the artificial dental root AR comprising the porous lamination component AR2 in the same way as described above by using the above-mentioned thin sheets AR4 having thickness values of 75, 100, 125 and 150 ⁇ m.
  • the thin sheet AR4 having a thickness of 175 ⁇ m was used, however, it had to be pulled strongly when it was wound around the circumference of the above-mentioned porous lamination component accommodation section AR9, resulting in breakage of the fixture holes AR6. To prevent this breakage, it was attempted to apply smaller tension force during the winding process. In this case, the thin sheet was not able to be wound accurately in accordance with the curvature of the porous lamination component accommodation section AR9. Even though an artificial dental root AR was obtained by winding the thin sheet AR4 in some way, only partial bonding was accomplished even when the artificial dental root AR was heated in the vacuum furnace. For this reason, no practical artificial dental root was able to be made.
  • the thin sheets having thickness values in the range of 50 to 100 ⁇ m were able to be used most easily for the production of the artificial dental root AR.
  • the femoral prosthesis ARf shown in Fig. 24 has a porous lamination component ARf2 around the circumference of a bone embedding section ARfl.
  • This porous lamination component can be formed by the same method as that used to make the porous lamination component AR2 of the above-mentioned artificial dental root AR, wherein the process of winding the thin sheet AR4 is included.
  • FIG. 25 shows an artificial hip joint AH.
  • This artificial hip joint AH comprises a hemispherical acetabular shell body AH 1 to be secured to a pelvis, a rod-shaped femoral stem AH2 to be inserted into a femoral medullary cavity, a hemispherical ball member AH4 to be fit in the leading end of a rod-shaped member AH3 extending at about 45 degrees from one end of the femoral stem AH2 and a bearing member AH5 used to form a ball joint in combination with the ball member AH4 and inserted in the interior of the acetabular shell body AH1.
  • An acetabular porous lamination component AH6 and a femoral stem porous lamination component AH7 are formed on the surfaces of the acetabular shell body AH1 and the femoral stem AH2.
  • the acetabular shell body AH1 and the femoral stem AH2 are made of a titanium alloy, and the acetabular porous lamination component AH6 and the femoral stem porous lamination component AH7 are made of pure titanium.
  • the acetabular porous lamination component AH6 is disposed in the greater part of the region where it directly contacts the pelvis.
  • the femoral stem porous lamination component AH7 is formed mainly around the entire circumference in the proximal region of the femoral medullary cavity.
  • Fig. 26 is a plan view of the thin sheet AH7 used to form the acetabular lamination component AH6.
  • the thin sheet AH7 with a thickness of 100 f..lm has a non-pore fringe portion AH8 with a width of 1 mm around the entire circumference thereof and is provided with a plurality of through holes H with an effective diameter of about 300 ⁇ m in the other sections.
  • the thin sheet AH7 has a shape comprising several pieces of roughly isosceles triangular forms arranged continuously along the extension line of the base sides of the triangular forms, wherein each triangular form is made by respectively connecting the ends of the base side with the ends of the top side (shorter than the base side) of each fragmental section of the thin sheet using curved lines.
  • the shape of the thin sheet AH7 is almost equal to the shape obtained by unfolding a spherical surface.
  • Fig. 27 is a side view illustrating only the above-mentioned acetabular shell body AH1.
  • the acetabular shell body AH 1 is roughly a hemisphere with a diameter of 50 mm.
  • an acetabular porous lamination component accommodation section AH9 having a spherical surface with a diameter of 48 mm is formed coaxially with the acetabular shell body AH1.
  • the top end of the accommodation section AH9 is positioned 5 mm below the vertex of the acetabular shell body AH1.
  • an internal ball with a diameter of 45 mm is included, which contacts the bearing member AH5.
  • Fig. 28 shows a condition wherein the acetabular lamination component AH6 is formed on the acetabular porous lamination component accommodation section AH9 of the acetabular shell body AH1.
  • the acetabular shell body AH1 is enclosed by metal molds 01 and 02.
  • Fig. 29 is a sectional view taken on line II-II of Fig. 28.
  • the metal molds 01 and 02 have an external shape obtained by dividing a cylinder measuring 70 mm in outer diameter and 50 mm in height into two pieces on the flat plane including the central axis of the cylinder.
  • a hemispheric bore 03 with a diameter of 50.5 mm is provided to allow the thin sheet AH7 to be formed around the entire circumference of the acetabular porous lamination component accommodation section AH9.
  • the acetabular shell body AH1 and ten pieces of the thin sheets AH7 are inserted in the metal molds 01 and 02 provided as described above, and the metal molds are made contact with each other at their division surfaces, the thin sheets AH7 are deformed into a hemispheric form inside the acetabular porous lamination component accommodation section AH9.
  • screws can be used to pull the molds.
  • the thin sheets AH6 can also be bent by pressing them against a cylindrical shaft with a diameter of 50 mm beforehand.
  • the acetabular porous lamination component accommodation section AH9 is bonded to the surface of the acetabular shell body AH1.
  • the object for obtaining a hemispherical surface can be attained by partially supporting the thin sheets at about three points.
  • Fig. 30 is a side view of the femoral stem AH2.
  • a femoral stem porous lamination component accommodation section AH12 is provided around the entire circumference of the stem AH2 in a width of about 60 mm.
  • the femoral stem porous lamination component accommodation section AH12 comprises two flat surfaces and two curved surfaces, and these surfaces are partitioned by bank-shaped projections AH13.
  • Fig. 31 is a sectional view taken on line III-III of Fig. 30.
  • the cross section is symmetrical and comprises flat surfaces with a width of about 18 mm, curved surfaces with radius curvatures of 6 and 25 mm and widths of 10 and 14 mm, and the bank-shaped projections AH13 used to partition the surfaces.
  • Fig. 32 is a plan view of the thin sheet AH7.
  • the size of the external shape thereof is slightly smaller than that of the femoral stem porous lamination component accommodation section AH12.
  • the thin sheet AH7 has a thickness of 100 ⁇ m and is provided with non-pore fringe portion AH14 with a width of about 1 mm around the entire circumference of the thin sheetAH7.
  • a plurality of through holes H with an effective diameter of about 300 ⁇ m are provided.
  • Fig. 33 shows a condition wherein a femoral stem porous lamination component AH16 is formed in the femoral stem AH2.
  • Metal molds 04, 05 and 06 respectively correspond to the corresponding sections on the femoral stem porous lamination component accommodation section AH12.
  • a form setting surface 09 is provided to form ten layers on the thin sheets AH7.
  • stop surfaces 07 and 08 are provided so that the metal molds 04, 05 and 06 can be secured at the predetermined positions.
  • the metal molds are put in the vacuum furnace and heated at 900°C, the femoral stem porous lamination component AH16 can be formed in the femoral stem AH2.
  • the porous lamination component AH16 can also be formed as described below.
  • a lamination component comprising thin sheets is heated to have a porous condition, it is cut by laser processing so that it can fit in the femoral stem porous lamination component accommodation section AH12, then it is formed by using the above-mentioned metal molds, thereby obtaining the porous lamination component AH16.
  • the porous lamination component is formed to have a curved surface, it can be bent beforehand in accordance with the curvature of the surface.
  • Fig. 34 is a perspective view on a femoral head cup AC on the present invention.
  • the femoral head cup AC is a hemisphere with a diameter of 38 to 60 mm. It comprises a 2 mm thick sliding component AC1 made of PVA (polyvinyl alcohol) on the outside thereof and a 2 mm thick porous lamination component AC2 having a three-layer structure described below on the inside thereof. Accordingly, the cup has a thickness of 4 mm and functions as a sliding member used to slide with the acetabulum after the cup is replaced with the femoral head.
  • PVA polyvinyl alcohol
  • Fig. 35 is a sectional view taken on line IV IV of Fig. 34.
  • the above-mentioned porous lamination component AC2 has a three-layer structure comprising a PVAjoint section AC4 having through holes H with an effective diameter of about 3 mm and being filled with PVAon the entire surface thereof and made by laminating five pieces of 100 f..lm thick pure titanium sheets, a bone contacting section AC5 having through holes H with an effective diameter of 300 f..lm on the entire surface thereon on the side of internal space E and made by laminating ten pieces of 50 ⁇ m thick pure titanium sheets, and a 1 mm thick cup component AC3 having no through holes, made on pure titanium and intervened between the PVAjoint AC4 and the bone contacting section AC5.
  • an appropriate amount of an adjusted PVA solution was poured into a metal mold (not shown).
  • the above-mentioned porous lamination component AC2 was then placed on the mold, with the side of the internal space E facing upward.
  • the metal mold and the porous lamination component AC2 were cooled for a while so as to fix PVAaround the porous lamination component AC2, then put into silicone oil at 140°C for heat treatment to form the sliding component AC1 comprising PVAgel having a low water content on the outside of the porous lamination component AC2, thereby obtaining the above-mentioned femoral head cup AC.
  • the above-mentioned PVA solution was adjusted in accordance with the method disclosed by Japanese Laid-open Patent Application No. 2-86606 and No. 3141957 by adding 10 g of PVA having a polymerization degree of 5000 and a saponification degree of 99.9 mol % to a dimethylsulfoxide/water mixture solvent and by stirring the ingredients at 130°C nor two hours to dissolve them.
  • Fig. 36 shows a condition wherein the femoral head cup AC is fitted on the femoral bone FB.
  • the porous lamination components used to coat the surfaces of the prostheses can be integrated with not only the above-mentioned PVA but also organic materials such as superhigh molecular polyethylene or silicone to be used nor the sliding section members, impact load absorbing members or elastic deformation members of prostheses.
  • the porous lamination components are, therefore, superior in enhancing the strength of the members made on organic materials and in joining the organic material members to bone tissues with which the organic material members make contact.
  • Fig. 37 is a side view of an artificial vertebral body CE used as a prosthesis of the present invention.
  • the main body CE1 of this artificial vertebral body is a cubic component made of alumina ceramics, measuring 10 x 10 x 5 mm.
  • a porous lamination component CE2 having a thickness of 1 mm and made of titanium is integrated with the main body CE1.
  • the porous lamination component CE2 comprises ten laminated thin sheets, each having a thickness on 100 ⁇ m.
  • Fig. 38 is a top view of the artificial vertebral body CE used as a prosthesis of the present invention.
  • the porous lamination component CE2 has most densely arranged through holes H with an effective diameter of 300 f..lm to form three-dimensional pores as shown in Fig. 39.
  • a joint-use cylinder CE3 measuring 0.98 mm in height and 2 mm in diameter is projecting.
  • six deformation absorbing grooves CE4 are disposed so as to enclose the joint-use cylinder CE3.
  • the pressure-fit surface CE5 making contact with the joint-use cylinder CE3 has a circular shape with a diameter of 2.3 mm.
  • Fig. 39 is a sectional view taken on line V-V of Fig. 38.
  • the above-mentioned porous lamination component CE2 is supported and secured by the joint-use cylinder CE3 of the main body CE1.
  • This assembly is then heated to about 900°C in the vacuum furnace so that the titanium thin sheets causes diffusion bonding.
  • paste including titanium particles is applied to the end surface of the above-mentioned main body CE1
  • the titanium particles combine with the metallic atoms of the porous lamination component CE2.
  • the melted titanium on the thin sheets penetrates the small through holes disposed in the alumina ceramics of the main body CE1 at the end surface thereon to provide an anchoring effect.
  • the joint between the porous lamination component CE2 and the main body CE1 is further enhanced.
  • the prosthesis of this example can be widely applied to the structures for surfaces making contact with bone tissues, such as femoral bone components of artificial knee joints made of ceramics, tibia components, iliac bone spacers, cranial bone prostheses and rib pins.
  • bone tissues such as femoral bone components of artificial knee joints made of ceramics, tibia components, iliac bone spacers, cranial bone prostheses and rib pins.
  • the prosthesis on the present invention can be firmly joined to living tissues by allowing the surrounding living tissues to promptly enclose the surfaces of the prosthesis after replacement and to penetrate the pores in the porous lamination component of the prosthesis and grow in the pores, thereby enhancing the durability of the prosthesis. Consequently, the present invention can provide prostheses which are not required to be replaced again, thereby imposing a less burden to patients.

Abstract

A prosthesis for the replacement of hard tissues of human bones and joints, comprising a porous lamination component of metal thin sheets, each having a plurality of through holes and a thickness of 150 µm or less, and being unharmful to the living body, the porous lamination component being formed such that the sheets are laid over one another and are then diffusion-bonded therebetween into one body by heating so that the through holes communicate with one another in the direction of the thickness thereof, and the prosthesis being entirely or partially composed of the porous lamination component. The present invention also relates to a method of making such a prosthesis.
The present invention can provide prostheses which are not required to be replaced again, thereby imposing a less burden to patients.

Description

    BACKGROUND OF THE INVENTION 1. Field of the Invention
  • The present invention relates to a prosthesis for the replacement of hard tissues such as human bones or joints having significantly deteriorated or lost functions thereof, and more particularly to a prosthesis having a porous surface structure capable of allowing bone tissues to penetrate so that the support/fixture characteristics of the joining section between the prosthesis and the living tissues can be enhanced. The present invention also relates to a method of making such a prosthesis.
  • 2. Prior Art
  • As conventional prostheses having porous surface structures capable of allowing bone tissues to penetrate, a plurality of prostheses have been proposed as follows:
    • (1) A metallic prosthesis having sintered and adhered metallic beads on the surface thereof, as disclosed by USP No. 3855638 and USP No. 4644942.
    • (2) A metallic prosthesis having compressed metallic meshes diffusion-bonded onto the surface thereof by heating at high temperature, as disclosed by EP No. 0178650 and USP No. 4660755.
    • (3) A prosthesis having porous metallic sheets secured mechanically to the surface thereof, as disclosed by GB No. 2142830A.
    • (4) A prosthesis having a porous surface structure with small through holes made by laser processing, as disclosed by USP No. 4608052.
    • (5) A prosthesis having a cast porous component secured to the surface thereof, as disclosed by Japanese Laid-open Patent Application No. 3-123546.
    • (6) A metall ic prosthesis having a surface structure with through holes, the shape on which is almost similar to that on the cancellous bone tissue, as disclosed by Japanese Laid-open Patent Application No. 3-29649.
    • (7) A prosthesis having a porous lamination component comprising laminated thin sheets, each having through holes provided by punching or etching and a thickness on 150 to 500 f..lm, made by applying a compression load and heating, or a prosthesis whose surface is partially or entirely coated with the porous lamination component, as disclosed by Japanese Laid-open Patent Application No. 3-49766.
  • The above-mentioned prostheses, however, have the following problems. The prosthesis (1) has a low volume porosity (the ratio of the volume on pores to the entire volume of the porous component thereof); it is generally said that the typical volume porosity of the above-mentioned conventional prostheses is about 35%. When this volume porosity is low, the relative volume of the bone tissue is small even if the bone tissue completely fills up all pores. Accordingly, the strength of the bonding between the prosthesis and the bone joined thereto is not sufficiently large. In the case of the prosthesis wherein metallic beads are attached to the surface thereof, it is known that the mechanical strength of the prosthesis' base material is significantly lowered by high temperature in the sintering process wherein the beads are attached. According to a report, for example, the fatigue strength of such a prosthesis is lowered to about 1/5 on that of the base material. The sintering process thus significantly adversely affects the durability of the prosthesis when used in the living tissue. In addition, since the bonding strength obtained among the above-mentioned beads is low, the beads may drop after sintering and may be in danger of penetrating articulation surfaces.
  • In the above-mentioned prosthesis (2), the volume porosity of the porous lamination component thereof is about 50% and the fatigue strength of the porous lamination component is about 70% of the base material thereof, showing a considerable improvement when compared with the above-mentioned prosthesis (1). It is however difficult to control the size and shape of small through holes within desired ranges in the compression process. As a result, the size and shape on the small through holes to be formed are not best suited for the penetration and ingrowth of the bone tissue. Furthermore, the above-mentioned porous lamination component has a disadvantage of generating a great difference in the size and shape on the through holes between those formed in the flat surfaces and those formed in the curved surfaces of the prosthesis because of the difference in the compression load. This changes the degree of the penetration of the bone tissue into the small through holes depending on the portion of the prosthesis, and causes the problem of generating different strength of the bonding between the porous lamination component and the bone to be joined depending on the portion of the prosthesis.
  • In the case of the prosthesis (3), since the above-mentioned sheets are mechanically bonded to the main body, the sheets cause micro-movements, resulting in wear or melting of the metallic structure thereon, and also resulting in the removal of the sheets in the worst case. This prosthesis is thus not applicable to portions having complicated curved surfaces. In addition, the cost of making the prosthesis is not inexpensive.
  • The above-mentioned prosthesis (4) has a surface structure having through holes with a diameter of about 300 f..lm disposed regularly. The through holes however are not open pores communicating with one another but closed pores, thereby preventing bio-liquid from flowing among bone cells, causing the problem of necrosis at the leading ends on the bone cells.
  • In the case of the above-mentioned prosthesis (5), since the porous lamination component thereof is made by casting, it is difficult to apply the porous lamination component to portions having complicated curved surfaces. Furthermore, the production cost is high because casting is used.
  • The above-mentioned prosthesis (6) has a surface structure similar to that of a cancellous bone in size and shape. The size and shape of the through holes in this structure are, however, not best suited for the penetration of bone tissues, thereby causing the problem on preventing bone tissues from sufficiently penetrating the through holes.
  • In the case on the above-mentioned prosthesis (7), since the thin sheets thereof are as thick as 150 to 500 f..lm, the porous lamination component thereof cannot be used for complicated curved surfaces or small- diameter cylindrical surfaces. Furthermore, the shape and arrangement on the holes are significantly deformed and dislocated by lamination and compression. It is therefore difficult to properly control the through hole shape best suited for the penetration of bone tissues, thereby causing the problem of preventing bone tissues from sufficiently penetrating the through holes.
  • SUMMARY OF THE INVENTION
  • To solve the above-mentioned problems, the object of the present invention is to provide a prosthesis for the replacement of hard tissues of human bones or joints, comprising a porous lamination component of metallic thin sheets, each having a plurality of through holes and a thickness of 150 µm or less and being unharmful to the living body, or a prosthesis which is partially composed of the above-mentioned porous lamination component at a desired surface portion on the prosthesis base. The term "base" here implies a portion to be embedded in the living bone tissue (hereinafter only referred to as "base"). Another object of the present invention is to provide a method on making such a prosthesis.
  • BRIEF DESCRIPTION OF THE DRAWINGS
    • Fig. 1 is a perspective view of a porous lamination component of an example of the present invention.
    • Fig. 2 is a plan view illustrating the arrangement of through holes in the thin sheets of the porous lamination component shown in Fig. 1.
    • Fig. 3 is a view taken on line I-I of Fig. 1,
    • Fig. 4 is a vertical sectional view of the porous lamination component of another example of the present invention.
    • Fig. 5 is a plan view illustrating a flat surface shape of a thin sheet of the present invention.
    • Fig. 6 is a plan view illustrating another flat surface shape on a thin sheet of the present invention.
    • Fig. 7 is a plan view illustrating still another flat surface shape of a thin sheet of the present invention.
    • Fig. 8 is a vertical sectional view of a porous lamination component on the present invention, illustrating a lamination condition of the through holes.
    • Fig. 9 is a view similar to Fig. 8, illustrating another lamination condition on the through holes.
    • Fig. 10 is a view similar to Fig. 8, illustrating still another lamination condition of the through holes.
    • Fig. 11 is a schema illustrating an animal experiment using the porous lamination component shown in Fig. 3.
    • Fig. 12 is a view similar to Fig. 11, illustrating another animal experiment.
    • Fig. 13 is a view similar to Fig. 11, illustrating still another animal experiment
    • Fig. 14 is a graph illustrating the measurement results of the adhesion strength of a porous lamination component of the present invention.
    • Fig. 15 is a microphotograph illustrating a histopathological examination result of a porous lamination component of the present invention used for an animal experiment.
    • Fig. 16 is a microphotograph illustrating another histopathological examination result of a porous lamination component of the present invention used for an animal experiment.
    • Fig. 17 is a microphotograph illustrating still another histopathological examination result of a porous lamination component of the present invention used for an animal experiment.
    • Fig. 18 is a perspective view illustrating an artificial vertebral body of the present invention.
    • Fig. 19 is a side view illustrating a condition wherein the artificial vertebral body shown in Fig. 18 is inserted between intervertebral disks.
    • Fig. 20 is a perspective view illustrating an artificial dental root of the present invention.
    • Fig. 21 is a top view illustrating the band-shaped thin sheet shown in Fig. 21.
    • Fig. 22 is a sectional view illustrating a method of laminating the porous lamination component for the artificial denial root shown in Fig. 21.
    • Fig. 23 is a side view illustrating the main body of the artificial dental root shown in Fig. 21.
    • Fig. 24 is a perspective view illustrating a femoral prosthesis of the present invention.
    • Fig. 25 is a side view of an artificial hip joint of the present invention.
    • Fig. 26 is a plan view illustrating the thin sheet used to form an acetabular porous lamination component on the present invention.
    • Fig. 27 is a side view of the acetabular shell body shown in Fig. 26.
    • Fig. 28 is a view illustrating a condition wherein an acetabular porous lamination component shown in Fig. 26 is formed.
    • Fig. 29 is a sectional view taken on line II-II of Fig. 28.
    • Fig. 30 is a side view of a femoral stem of the present invention.
    • Fig. 31 is a sectional view taken on line III-III on Fig. 30.
    • Fig. 32 is a plan view illustrating a thin sheet composing the porous lamination component for a femoral stem of the present invention.
    • Fig. 33 is a view illustrating a condition wherein the porous lamination component for a femoral stem of the present invention is formed.
    • Fig. 34 is a perspective view illustrating a femoral head cup on the present invention.
    • Fig. 35 is a sectional view taken on line IV-IV on Fig. 34.
    • Fig. 36 is a perspective view illustrating a condition wherein a femoral bone is replaced with a femoral head cup of the present invention.
    • Fig. 37 is a perspective view illustrating an artificial vertebral body of the present invention.
    • Fig. 38 is a top view of an artificial vertebral body of the present invention, and
    • Fig. 39 is a sectional view taken on line V-V of Fig. 38.
    DETAILED DESCRIPTION OF THE INVENTION
  • According to the present invention, porous thin sheets 1, 2,..., each having a thickness of 150 µm or less, are laminated and formed in a desired prosthesis shape, or laminated on the flat or curved surface of a prosthesis base. In the thin sheets 1, 2,..., small through holes H having a shape suited nor the penetration and ingrowth of a plurality of bone cells are provided. In addition, a prosthesis surface having a porous lamination component S1 with a three-dimensional cubic structure is formed by slightly displacing the positions of the through holes disposed in laminated thin sheets in the direction of the depth. The bone tissues penetrated and grown in the three-dimensional space inside the porous surface functions to firmly support the prosthesis in the living body by utilizing its cubic structure, thereby preventing the micro-movement of the prosthesis. Furthermore, by coating a bio-compatible material, in which bone cells can easily grow, on the laminated thin sheets, the penetration of bone cells can be promoted more promptly after the replacement operation of the prosthesis, thereby permitting earlier fixture to the bone to be joined. Moreover, when a prosthesis made by laminating the thin sheets 1,2,... having through holes H with an effective diameter of 100 to 400 µm is secured with bone cement, the fixture performance between the bone cement and the prosthesis can be enhanced significantly.
  • EXAMPLES
  • Referring to the accompanying drawings, the examples of the present invention will be explained specifically.
  • (Example 1)
  • Fig. 1 is a perspective view of a porous lamination component S1 comprising the whole of a prosthesis, or a part or the whole of the base surface of a prosthesis of the present invention. The porous lamination component S1 measures 10 x 15 x 2 mm. It has a sequentially laminated structure including 20 layers of porous thin sheets 1, 2,..., each having a thickness of 100 µm and a plurality of through holes. The thin sheets 1, 2,... are made of pure titanium. After the thin sheets 1, 2,... were positioned properly while being laminated, and secured temporarily by placing a very light weight on them or by using adhesive, they were heated at about 900°C in a vacuum sintering furnace so that they were bonded mutually. The heater of the sintering furnace is made on molybdenum. The heating process can be conducted in an atmosphere of inert gas such as argon. The bonding on the thin sheets 1, 2,... was conducted by diffusion-bonding between metal atoms. The thin sheets 1,2,... were positioned by utilizing the rectangular sides thereof as reference sides. In the process inside the vacuum furnace, although the overlap on the through holes H may be dislocated slightly, the amount on the dislocation is about 20 f..lm and is almost negligible nor proper production. If more precise overlap is necessary, or in the external shape of the porous lamination component S1 has a shape other than a cube and has not any flat surface portions which can be used as reference surfaces, positioning holes (notshown) should preferably be provided at the four corners of the thin sheets 1, 2,... Afterthe thin sheets 1,2,...were diffusion-bonded mutually in this way, no special change was recognized in the appearance and dimensions on the porous lamination component S1 and no deteriorated layer was recognized.
  • Fig. 2 shows a magnified view of regular hexagonal through holes H formed in the thin sheets 1, 2, 3,4,... of the above-mentioned porous lamination component S1. The shape of the regular hexagonal through holes H is one of shapes suited for easy penetration and dense ingrowth of osteon, the minimum unit of bone tissues. The shape is also suited for allowing the highest density filling arrangement on the through holes.in the same way as that shown in honeycombs and crystal structures. As the dimension on a pore which permits bone tissues to penetrate easily, the diameter of the inscribed circle on the through hole H of this example was determined to be about 350 µm. Since the etching method as described below was used to form the through holes H in this example, the central sectional portion of the through hole H was raised. The diameter of the inscribed circle at the mostly raised portion became about 300 µm. The porous lamination component S1 was designed as shown in Fig. 2; the horizontal width of the non-pore fringe portion P1 = 1.05 mm, the vertical width of the non-pore fringe portion P2 = 1.27 mm, the horizontal interval between the through holes PI = 500 µm, and the vertical interval between the through holes Pm = 433 µm, thereby most densely arranging the through holes H with an effective diameter of 350 µm. The space t between the through holes H resulted in 150 µm. The volume porosity of the pores in the porous lamination component S1 designed in this way is about 50% per unit volume, that is, the volume porosity of the porous lamination component S1 is 50%. In this way, the volume porosity of the porous lamination component S1 can be easily controlled by appropriately adjusting the effective diameter of the through holes H, the interval between the through holes H and the combination of lamination layers. For example, in PI = 450 µm and Pm = 383 µm in the above example, the volume porosity can be changed to about 60%. Furthermore, if PI = 450 µm, Pm = 383 µm and the effective diameter of the through holes H is 400 µm in the above example, the volume porosity can be changed to about 75%. The volume porosity should preferably be as large as possible to make the amount of bone tissues to penetrate as much as possible.
  • The above-mentioned through holes H were formed by an etching method. The through holes H can also be formed by laser processing or punching.
  • Fig. 3 is a sectional view of the porous lamination component S1 taken on line I-I of Fig. 1. To design the distribution of the through holes H, the through hole H disposed at the n-th line and the m-th column of the first layer is defined to be represented as 1Hnm. The through hole H represented by 1H11 is a through hole disposed at the first line and the first column of the first layer. The thin sheets 1, 2,... with a thickness of 100 µm are laminated and the through holes 1 H11 and 2H11 communicate with each other. In actual practice, however, the layers of the porous lamination component S1 are often dislocated slightly as described above. When the thin sheet is corroded on both sides thereof in the etching liquid showering process to form through holes H, the cross section of the sheet has a shape similarto a rhombus because of the projection section projecting toward the center of the through hole H as shown in the figure, and the angle of the inclined surface thereof is in the range of about 30 to 45 degrees. If the thin sheet is etched on the one side thereof, the cross section of the sheet has a shape similar to an isosceles triangle. Whether the thin sheet is etched on both sides or on one side is determined by considering the shape of the prosthesis to be used and the biomechanical conditions at the hard tissue portion to be replaced. More particularly, it is necessary to consider what kind of stress and how much stress remains on the surface of the porous lamination component S1. In addition, when bone cement is used for fixture, the porous lamination component S1 should be designed so that bone cement can easily penetrate the through holes H and cannot come out easily after polymerization.
  • The porous lamination component S1 processed as described above has slight dislocations at laminated portions. For example, the positions of the through holes 1 H11 and 2H11 are dislocated slightly from their designed positions. If the through holes H in the thin sheets 1, 2,... are designed to be disposed alternately as shown in Fig. 4, more spaces can be provided to guide bone tissues. With this structure, bone tissues can penetrate the prosthesis for an extended period of time, thereby being more effective for the support of the prosthesis. This kind of uniform plan view shape and three-dimensional structure of the through holes H can be formed on any prosthesis surfaces by utilizing the present invention. The plan view shape of the through holes H should preferably be a regular hexagonal shape having the highest density filling efficiency, and should also be a shape capable of increasing the volume porosity as large as possible. In addition, the through holes H adjacent to one another should preferably have open three-dimensional structures contacting one another. Furthermore, to shorten the period requiring nor permitting bone tissues to penetrate, the through holes H should preferably be coated with a bio-active living body material having affinity to bone tissues. As the material used for coating, bioglass ceramics, chitin, chitosan and gelatin can be nominated. In particular, when no bio-active living body material is coated, titanium oxide coating or titanium nitride coating superior in corrosion resistance in the living body should preferably be used to prevent metal ions from flowing out. Moreover, when bone cement is used to secure the prosthesis, the through holes H should preferably be coated with an agent, such as a silane coupling agent, which can strengthen the force of adhesion to bone cement.
  • Figs. 5, and 7 show various plan view shapes of the through holes H. The plan view shapes of the through holes H should be suited for the penetration of bone cells. Fig. 5 shows the through holes H disposed at the highest density arrangement. Fig. 6 shows the through holes H with various diameters. Although it is generally said that pores with an inscribed circle diameter on 75 to 350 f..lm are suited for promoting the penetration of bone cells, a plan view shape having distributed pores with various diameters in a constant area, such as that shown in Fig. 6, can also be considered to be effective. This kind of plan view shape can also be obtained easily by utilizing the present invention. In some cases, indeterminate forms of through holes H shown in Fig. 7 may be desirable. Depending on the kind of bone cells, a proper response may not necessarily be obtained by circular through holes, but a tapered shape may be preferable.
  • Figs. 8, 9 and 10 show the sectional structures on the through holes H in the laminated thin sheets 1, 2,... Fig. 8 shows a sectional structure wherein the effective dimensions of the through holes H disposed in the thin sheets 1, 2,... become smaller as the through holes H are disposed closer to the prosthesis base I from the bone tissue side B. Fig. 9 shows a sectional structure which is opposite to that shown in Fig. 8. This sectional structure is particularly effective when a tension load is applied to the porous lamination component surface. Fig. 10 shows a sectional structure wherein the areas on the through holes H in the second and fourth layers are especially larger than those of the through holes in the other layers. When the shape of the prosthesis base I is curved and the curvature of the shape is small, the positional relationship among the thin sheets are dislocated slightly. Although it is possible to design the thin sheets 1,2,... by considering the effect of the slight dislocation previously estimated, the dislocation can be neglected to some extent by using the structure shown in Fig. 10. In addition, it is also said that the structure wherein the diameters of the through holes H are made larger in the upward or downward direction is suited for the ingrowth of bone tissues.
  • Fig. 11 shows a schema illustrating the porous lamination component S1 made as described above and used for an animal experiment to examine the effectiveness thereof. The porous lamination component S1 used for this experiment has through holes H which pass through straight in the vertical direction as shown in Fig. 3. The effective diameter of the through hole H is 350 f..lm and the volume porosity of the porous lamination component S1 is 60%. The experiment was conducted in accordance with the method described in the Journal of Biomedical Materials Research (hereinafter referred to as "JBMR"), Vol. 20, 1295-1307 (1986). The porous lamination component S1 was embedded at a position about 3 cm from a mesial tibia T of rabbits. The porous lamination component S1 was cleansed, autoclaved, and wetted with a saline solution including a dissolved antibiotic. The porous lamination component S1 was then embedded into a gutter by pounding it with a hammer. The periosteum, muscle, fascia and skin were stitched up together in accordance with the conventional methods. After the antibiotic was given, the treatment portion was laid quietly. Each rabbit was allowed to move freely in a cage (50 x 80 x 40 cm) and was fed with solid food and water.
  • The rabbits were killed four and six weeks after operation. As shown in Fig. 12, the porous lamination component S1 and a part of the tibia T around the porous lamination component were taken out. After about two hours, without formalin fixation, a wire W was passed through the tibia T as shown in Fig. 13 and the adhesion strength D of the structure was measured by using an instron testing machine. The loading condition of the instron testing machine was given at a cross head speed of 3.5 cm/min in accordance with the above-mentioned method.
  • Fig. 14 is a graph illustrating the measurement results of the adhesion strength D. The points marked 0 indicate the adhesion strength of the porous lamination component S1 of the present invention. The adhesion strength of the porous lamination component S1 was about 10 kg five weeks after adhesion. After ten weeks, the adhesion strength of the S1 was about 12 kg. The adhesion strength per unit area was 6 kg/cm2 after five weeks and 8 kg/cm2 after ten weeks. Breakage occurred in the tibia T attached to the porous lamination component S1. No separation was observed at the interfaces of the thin sheets of the porous lamination component S1. The points marked o indicate the adhesion strength of the bioglass ceramics reported in the above-mentioned literature. It was reported that the average adhesion strength was 7.61 kg after ten weeks and 7.24 kg after 25 weeks. As reported in JBMR, Vol. 23, 781-808 (1989), the average adhesion strength of hydroxyapatite was 6.40 kg after eight weeks and 6.86 kg after 25 weeks as indicated by the points marked 4. The points marked D indicate the strength of the bone. It was reported that the average adhesion strength was 11.96 kg after 25 weeks according to JBMR, Vol. 19,685-698 (1985). Since these experiments were conducted in the same conditions, the values of the measurement results can be used for comparison. According to these results, it is found that the porous lamination component S1 of the present invention is superior to the bioglass ceramics and hydroxyapatite, which are assumed to be the most bio-active materials among the currently available living body materials in terms of the performance of bonding and adhesion to bone tissues. It is also found that the adhesion strength of the prosthesis reaches a value almost similar to the strength of the bone in a short period of about ten weeks.
  • Figs. 15, 16 and 17 are microphotographs illustrating the histopathological examination results of the porous lamination component S1 used for the adhesion strength measurement tests.
  • The bone tissues obtained afterthe adhesion strength tests and the porous lamination component S1 were subjected to dehydration and resin embedding in accordance with the conventional methods, and sliced in the direction perpendicular to the longitudinal axis of the tibia T, then manually processed to obtain ground sections Z with a thickness of up to about 50 µm. The sections were observed by using a light microscope in accordance with the normal light microscopy method and the fluorescent microscopy method.
  • Fig. 15 is a microphotograph at 5500 magnifications. It is found that bone tissue A and marrow tissue B coexist in the through holes H in the regions of the thin sheets 1 to 5. In addition, blood vessel tissues and new osteoblasts were observed with the naked eye, although they were not taken clearly on the microphotograph. Fig. 16 shows a fluorescent microscopic image of the image shown in Fig. 15.
  • Fig. 17 shows the regions corresponding to the thin sheets 11 to 15. Although the amount of the bone tissue A is smaller, there are no great differences in the calcification degree and the adhesion strength of the bone tissue.
  • As shown in Figs. 15 to 17, the bone tissue A penetrated almost all through holes H of the thin sheets 1 to 20 of the porous lamination component S1 grew in the through holes. It is found that the tissue A is a normal bone tissue including marrow tissue B. This result indicates that a complex substance is formed between the surface of the porous lamination component of the present invention and the bone and that the metallic thin sheets reinforce the bone tissues. In addition, it is found that the bonding strength of the porous lamination component S1 is sufficient and that the force of adhesion to the bone is almost equal to the breakage force of the bone itself.
  • Next, other samples of the porous lamination component S1 comprising thin sheets 1,2,... having different thickness values listed in Table 1 (different from the thickness of the thin sheets on the porous lamination component S1 used for the above-mentioned experiments) were made in accordance with the above-mentioned method. These samples of the porous lamination component S1 were used for the same animal experiments as those described above and the adhesion strength values were measured after ten weeks. The measurement results are shown in Table 1.
    Figure imgb0001
  • As obviously indicated by Table 1, when the above-mentioned thickness is in the range of 10 to 150 µm, the adhesion strength is 12 kg/cm2. This value is almost equal to the strength of the bone as described above. It was confirmed that a breakage occurred at the tibia T. On the other hand, when the thickness is larger than 150 µm, the adhesion strength is less than 10 kg/cm2. In this case, it was also confirmed that a breakage occurred in the porous lamination component S1.
  • This breakage occurrence is assumably explained as follows. When the above-mentioned thickness is in the range of 10 to 150 µm, the bone cells which penetrate the through holes H and grow therein are firmly anchored by the projection portions h of the thin sheets 1, 2,... projecting in the central direction of the through holes H as shown in the sectional view of Fig. 3. When the thickness is smaller than 10 f..lm, the amount of the projection at the projection portions his too small and the bone cells are not sufficiently supported, thereby being incapable of firmly anchoring the bone cells. When the thickness is larger than 150 µm, the amount of the projection at the projection portions h is large, and the diameter of the through holes H in the direction of the thickness is reduced to about 10 µm, thereby assumably resulting in the breakage of the bone tissues at the region of the reduced diameter portions.
  • Furthermore, when the thickness is smaller than 10 µm, the number of the thin sheets 1, 2,... to be laminated increases significantly. This makes the production of the porous lamination component extremely difficult.
  • Next, still other samples of the porous lamination component S1 comprising thin sheets 1, 2,... having the through holes alternately disposed as shown in Fig. 4 and also having different thickness values listed in Table 2 were made in accordance with the above-mentioned method. The shape of the through holes H in the porous lamination component S1 was hexagonal and its effective diameter was 300 µm and the volume porosity of the porous lamination component S1 was 60%. These samples of the porous lamination component S1 were subjected to the above-mentioned animal experiments and the adhesion strength values were measured after ten weeks. The measurement results are shown in Table 2.
    Figure imgb0002
  • As obviously indicated by Table 2, when the above-mentioned thickness is in the range of 10 to 150 µm, the adhesion strength is 12 kg/cm2. This value is almost equal to the strength of the bone as described above. It was confirmed that a breakage occurred at the tibia T. On the other hand, when the thickness is smaller than 10 µm or larger than 150 µm, the adhesion strength is less than 10 kg/cm2. In this case, it was confirmed that a breakage occurred in the porous lamination component S1.
  • Next, still other samples of the porous lamination component S1 comprising thin sheets 1, 2,... having a thickness of 100 µm and also having the through holes H with different effective diameters listed in Table 3 were made in accordance with the above-mentioned method. The cross sectional structure of this porous lamination component S1 had the through holes H alternately disposed in the thin sheets 1, 2,... as shown in Fig. 4 and the volume porosity of the porous lamination component S1 was 60%. These samples of the porous lamination component S1 were subjected to the above-mentioned animal experiments and the adhesion strength values were measured after ten weeks. The measurement results are shown in Table 3.
    Figure imgb0003
  • As obviously indicated by Table 3, when the above-mentioned effective hole diameter is in the range of 100 to 400 f..lm, the adhesion strength is 12 kg/cm2. This value is almost equal to the strength of the bone as described above. It was confirmed that a breakage occurred at the tibia T. On the other hand, when the diameter is smaller than 100 µm or larger than 400 µm, the adhesion strength is less than 10 kg/cm2. In this case, it was confirmed that a breakage occurred in the porous lamination component S1.
  • Next, yet still other samples of the porous lamination component S1 comprising thin sheets 1, 2,... having a thickness of 100 µm and the through holes H with an effective diameter of 300 µm and also having different volume porosity values listed in Table 4 were made in accordance with the above-mentioned method. The cross sectional structure of the porous lamination component S1 had the through holes H alternately disposed in the thin sheets 1, 2,... as shown in Fig. 4.
    Figure imgb0004
  • As obviously indicated by Table 4, when the above-mentioned volume porosity is more than 45%, the adhesion strength is 12 kg/cm2. This value is almost equal to the strength of the bone as described above. It was confirmed that a breakage occurred at the tibia T. On the other hand, when the volume porosity is less than 45%, the adhesion strength is less than 10 kg/cm2. In this case, it was confirmed that a breakage occurred in the porous lamination component S1.
  • Accordingly, it is found that the preferable thickness of the thin sheets 1,2,... is 150 µm or less, more particularly in the range of 10 to 150 µm, the preferable effective hole diameter is in the range of 100 to 400 µm and the preferable volume porosity of the porous lamination component S1 is 45% or more.
  • (Example 2)
  • Fig. 18 shows an artificial vertebral body AL used as a prosthesis of an example on the present invention. Ten pieces of 100 µm thick titanium thin sheets 1, 2,... having the same shape as that on the end surface of the artificial vertebral body ALwere laminated to form a porous lamination component AL2 having a thickness of about 1 mm and this porous lamination component AL2 was bonded to both ends of the cubic artificial vertebral bodyALmade of a titanium alloy. The effective diameterof the through holes H was 300 µm. Other design items were the same as those of the example 1.
  • The artificial vertebral main body AL1 laminated with the porous lamination component AL2 comprising the lamination of the above-mentioned thin sheets 1, 2,... as shown in Fig. 18 was heated up to about 900°C in a vacuum furnace in an atmosphere of inert gas (argon). The surfaces of the artificial vertebral body AL were then coated with hydroxyapatite by flame spray coating. Next, the hydroxyapatite was converted into a paste state, and recrystallized by heat treatment. Bioglass ceramics was then used for coating.
  • In addition, to coat hydroxyapatite on the internal wall surfaces of the through holes H of the above-mentioned porous lamination component AL2, an artificial vertebral body AL was made as described below.
  • First, both ends of the artificial vertebral main body AL1 were coated with hydroxyapatite, and the porous lamination components AL2 were laminated on the artificial vertebral main body AL1 and then these laminated components were heated in the vacuum furnace as described above. Hydroxyapatite was coated only on the internal wall surfaces of the through holes H disposed close to the interfaces between the porous lamination components AL2 and the artificial vertebral main body AL1.
  • Furthermore, hydroxyapatite coating was performed by flame spray coating on one end of the porous lamination component AL2 which had been made previously in accordance with the method used for example 1. By heating the spray-coated surface abutted to the artificial vertebral main body AL1 in the vacuum furnace, an artificial vertebral body AL, in which the internal wall surfaces of the through holes H were coated with hydroxyapatite only on the intermediate layers of the porous lamination component AL2, was obtained.
  • In this way, the coating range in the cross section of the porous lamination component can be controlled.
  • Fig. 19 is a side view illustrating the condition wherein a lumbar vertebra LB and an intervertebral disk LD are replaced with the above-mentioned artificial vertebral body AL.
  • In addition to the artificial vertebral body, this example can be applied to various prostheses such as spinous process spacers, iliac bone spacers, posterior cranial fossa plates and artificial knee joint tibial components.
  • (Example 3)
  • Fig. 20 is a perspective view illustrating an artificial dental root AR of the present invention. The artificial dental root AR comprises a cylindrical artificial dental root body AR1 and an artificial dental root porous lamination component AR2 formed around the cylindrical surface of the artificial dental root body AR1.
  • Fig. 21 is a plan view of a thin sheet AR4 which is used to form the artificial dental root porous lamination component AR2. The thin sheet AR4 has a shape of band measuring 50 µm in thickness, 7.9 mm in width and 1000 mm in length. It has a plurality of through holes H with an effective diameter of about 300 f..lm, with non-pore fringe portions AR5 having a horizontal width of about 1 mm provided around the external fringe of the band. Furthermore, at the leading end of the above-mentioned thin sheetAR4, two fixture holes AR6 are provided.
  • Fig. 22 is a sectional view illustrating a method of laminating the band-shaped artificial dental root porous lamination componentAR2 overthe porous lamination component accommodation section AR9 of the artificial dental root body AR1. The artificial dental root body AR1 was secured at the axial center thereof. Two 0.85 mm diameter titanium rods AR11 were respectively driven into the two thin sheet fixture holes AR10 disposed in the porous lamination component accommodation section AR9 of the artificial dental root body AR1 shown in Fig. 23. The above-mentioned fixture holes AR6 disposed in the thin sheet AR4 were fitted over the rods AR11. The projected portions of the rods AR11 were then removed by filing operation. After this, while the thin sheet AR4 was pulled to prevent it from being deflected, the artificial dental root body AR1 was rotated to wind the thin sheet AR4 around the artificial dental root body AR1.
  • Since the thickness of the thin sheet AR4 was 50 f..lm, the thickness of the artificial dental root porous lamination component AR2 was equal to the depth of the above-mentioned porous lamination component accommodation section, i. e., 1 mm after the thin sheet AR4 was rotated about 20 times. The thin sheet AR4 was then cut at an appropriate position, the trailing end thereof was temporarily secured by using adhesive and heated at about 900°C in the vacuum furnace.
  • Fig. 23 is a side view of the artificial dental root body AR1. The artificial dental root body AR1 is a cylinder with an overall length of 12 mm and comprises a 4 mm diameter end section AR7 disposed at one end thereof, a leading end section AR6 disposed at the other end thereof and having a round end, and the porous lamination component accommodation section AR9 disposed between the end section AR7 and the leading end section AR6 and having a length of about 8 mm and a diameter of 3 mm. The porous lamination component accommodation section AR9 is provided with two thin sheet fixture holes AR10 with a diameter of 0.8 mm in the porous lamination component accommodation section AR9.
  • It was possible to make the artificial dental root AR comprising the porous lamination component AR2 in the same way as described above by using the above-mentioned thin sheets AR4 having thickness values of 75, 100, 125 and 150 µm. When the thin sheet AR4 having a thickness of 175 µm was used, however, it had to be pulled strongly when it was wound around the circumference of the above-mentioned porous lamination component accommodation section AR9, resulting in breakage of the fixture holes AR6. To prevent this breakage, it was attempted to apply smaller tension force during the winding process. In this case, the thin sheet was not able to be wound accurately in accordance with the curvature of the porous lamination component accommodation section AR9. Even though an artificial dental root AR was obtained by winding the thin sheet AR4 in some way, only partial bonding was accomplished even when the artificial dental root AR was heated in the vacuum furnace. For this reason, no practical artificial dental root was able to be made.
  • According to the results of the actual practice, the thin sheets having thickness values in the range of 50 to 100 µm were able to be used most easily for the production of the artificial dental root AR.
  • The femoral prosthesis ARf shown in Fig. 24 has a porous lamination component ARf2 around the circumference of a bone embedding section ARfl. This porous lamination component can be formed by the same method as that used to make the porous lamination component AR2 of the above-mentioned artificial dental root AR, wherein the process of winding the thin sheet AR4 is included.
  • (Example 4)
  • Fig. 25 shows an artificial hip joint AH. This artificial hip joint AH comprises a hemispherical acetabular shell body AH 1 to be secured to a pelvis, a rod-shaped femoral stem AH2 to be inserted into a femoral medullary cavity, a hemispherical ball member AH4 to be fit in the leading end of a rod-shaped member AH3 extending at about 45 degrees from one end of the femoral stem AH2 and a bearing member AH5 used to form a ball joint in combination with the ball member AH4 and inserted in the interior of the acetabular shell body AH1.
  • An acetabular porous lamination component AH6 and a femoral stem porous lamination component AH7 are formed on the surfaces of the acetabular shell body AH1 and the femoral stem AH2. The acetabular shell body AH1 and the femoral stem AH2 are made of a titanium alloy, and the acetabular porous lamination component AH6 and the femoral stem porous lamination component AH7 are made of pure titanium.
  • The acetabular porous lamination component AH6 is disposed in the greater part of the region where it directly contacts the pelvis. The femoral stem porous lamination component AH7 is formed mainly around the entire circumference in the proximal region of the femoral medullary cavity.
  • Fig. 26 is a plan view of the thin sheet AH7 used to form the acetabular lamination component AH6. The thin sheet AH7 with a thickness of 100 f..lm has a non-pore fringe portion AH8 with a width of 1 mm around the entire circumference thereof and is provided with a plurality of through holes H with an effective diameter of about 300 µm in the other sections. The thin sheet AH7 has a shape comprising several pieces of roughly isosceles triangular forms arranged continuously along the extension line of the base sides of the triangular forms, wherein each triangular form is made by respectively connecting the ends of the base side with the ends of the top side (shorter than the base side) of each fragmental section of the thin sheet using curved lines. The shape of the thin sheet AH7 is almost equal to the shape obtained by unfolding a spherical surface.
  • Fig. 27 is a side view illustrating only the above-mentioned acetabular shell body AH1. The acetabular shell body AH 1 is roughly a hemisphere with a diameter of 50 mm. From the position 5 mm away from the end surface of the acetabular shell body AH1, an acetabular porous lamination component accommodation section AH9 having a spherical surface with a diameter of 48 mm is formed coaxially with the acetabular shell body AH1. The top end of the accommodation section AH9 is positioned 5 mm below the vertex of the acetabular shell body AH1. In the interior of the accommodation section AH9, an internal ball with a diameter of 45 mm is included, which contacts the bearing member AH5.
  • Fig. 28 shows a condition wherein the acetabular lamination component AH6 is formed on the acetabular porous lamination component accommodation section AH9 of the acetabular shell body AH1. The acetabular shell body AH1 is enclosed by metal molds 01 and 02. Fig. 29 is a sectional view taken on line II-II of Fig. 28. The metal molds 01 and 02 have an external shape obtained by dividing a cylinder measuring 70 mm in outer diameter and 50 mm in height into two pieces on the flat plane including the central axis of the cylinder. Inside the molds, a hemispheric bore 03 with a diameter of 50.5 mm is provided to allow the thin sheet AH7 to be formed around the entire circumference of the acetabular porous lamination component accommodation section AH9. When the acetabular shell body AH1 and ten pieces of the thin sheets AH7 are inserted in the metal molds 01 and 02 provided as described above, and the metal molds are made contact with each other at their division surfaces, the thin sheets AH7 are deformed into a hemispheric form inside the acetabular porous lamination component accommodation section AH9. To make the metal molds 01 and 02 contact with each other, screws can be used to pull the molds. The thin sheets AH6 can also be bent by pressing them against a cylindrical shaft with a diameter of 50 mm beforehand. By heating the thin sheets AH7 to about 900°C in the vacuum furnace, the acetabular porous lamination component accommodation section AH9 is bonded to the surface of the acetabular shell body AH1. To form a hemispherical porous lamination component, it is not always necessary to use hemispherical surfaces such as those provided in the metal molds 01 and 02, the object for obtaining a hemispherical surface can be attained by partially supporting the thin sheets at about three points.
  • Fig. 30 is a side view of the femoral stem AH2. In the middle section of the femoral stem AH2, a femoral stem porous lamination component accommodation section AH12 is provided around the entire circumference of the stem AH2 in a width of about 60 mm. The femoral stem porous lamination component accommodation section AH12 comprises two flat surfaces and two curved surfaces, and these surfaces are partitioned by bank-shaped projections AH13.
  • Fig. 31 is a sectional view taken on line III-III of Fig. 30. The cross section is symmetrical and comprises flat surfaces with a width of about 18 mm, curved surfaces with radius curvatures of 6 and 25 mm and widths of 10 and 14 mm, and the bank-shaped projections AH13 used to partition the surfaces.
  • Fig. 32 is a plan view of the thin sheet AH7. The size of the external shape thereof is slightly smaller than that of the femoral stem porous lamination component accommodation section AH12. The thin sheet AH7 has a thickness of 100 µm and is provided with non-pore fringe portion AH14 with a width of about 1 mm around the entire circumference of the thin sheetAH7. In the othersections of the thin sheet AH7, a plurality of through holes H with an effective diameter of about 300 µm are provided.
  • Fig. 33 shows a condition wherein a femoral stem porous lamination component AH16 is formed in the femoral stem AH2. Metal molds 04, 05 and 06 respectively correspond to the corresponding sections on the femoral stem porous lamination component accommodation section AH12. A form setting surface 09 is provided to form ten layers on the thin sheets AH7. Furthermore, stop surfaces 07 and 08 are provided so that the metal molds 04, 05 and 06 can be secured at the predetermined positions. When the metal molds are put in the vacuum furnace and heated at 900°C, the femoral stem porous lamination component AH16 can be formed in the femoral stem AH2. The porous lamination component AH16 can also be formed as described below. After a lamination component comprising thin sheets is heated to have a porous condition, it is cut by laser processing so that it can fit in the femoral stem porous lamination component accommodation section AH12, then it is formed by using the above-mentioned metal molds, thereby obtaining the porous lamination component AH16. When the porous lamination component is formed to have a curved surface, it can be bent beforehand in accordance with the curvature of the surface.
  • Fig. 34 is a perspective view on a femoral head cup AC on the present invention. The femoral head cup AC is a hemisphere with a diameter of 38 to 60 mm. It comprises a 2 mm thick sliding component AC1 made of PVA (polyvinyl alcohol) on the outside thereof and a 2 mm thick porous lamination component AC2 having a three-layer structure described below on the inside thereof. Accordingly, the cup has a thickness of 4 mm and functions as a sliding member used to slide with the acetabulum after the cup is replaced with the femoral head.
  • Fig. 35 is a sectional view taken on line IV IV of Fig. 34. The above-mentioned porous lamination component AC2 has a three-layer structure comprising a PVAjoint section AC4 having through holes H with an effective diameter of about 3 mm and being filled with PVAon the entire surface thereof and made by laminating five pieces of 100 f..lm thick pure titanium sheets, a bone contacting section AC5 having through holes H with an effective diameter of 300 f..lm on the entire surface thereon on the side of internal space E and made by laminating ten pieces of 50 µm thick pure titanium sheets, and a 1 mm thick cup component AC3 having no through holes, made on pure titanium and intervened between the PVAjoint AC4 and the bone contacting section AC5.
  • Next, the method of making the above-mentioned femoral head cup AC is described below. First, thin sheets, each having through holes H with an effective diameter of 300 µm and a thickness of 50 µm, and other thin sheets, each having through holes H with an effective diameter of 3 mm and a thickness of 100 µm, were made by using the spherical surface unfolding method described for the example 4. Five pieces of the former thin sheets and five pieces of the latter thin sheets were laminated on both sides of the above-mentioned cup component AC3. These were temporarily secured and put into a metal mold (not shown). The metal mold was then put into the vacuum furnace and heated at about 900°C so that they were bonded. In this way, the above-mentioned porous lamination component AC2 was made.
  • Next, an appropriate amount of an adjusted PVA solution was poured into a metal mold (not shown). The above-mentioned porous lamination component AC2 was then placed on the mold, with the side of the internal space E facing upward. The metal mold and the porous lamination component AC2 were cooled for a while so as to fix PVAaround the porous lamination component AC2, then put into silicone oil at 140°C for heat treatment to form the sliding component AC1 comprising PVAgel having a low water content on the outside of the porous lamination component AC2, thereby obtaining the above-mentioned femoral head cup AC.
  • The above-mentioned PVA solution was adjusted in accordance with the method disclosed by Japanese Laid-open Patent Application No. 2-86606 and No. 3141957 by adding 10 g of PVA having a polymerization degree of 5000 and a saponification degree of 99.9 mol % to a dimethylsulfoxide/water mixture solvent and by stirring the ingredients at 130°C nor two hours to dissolve them.
  • Fig. 36 shows a condition wherein the femoral head cup AC is fitted on the femoral bone FB.
  • As described above, the porous lamination components used to coat the surfaces of the prostheses can be integrated with not only the above-mentioned PVA but also organic materials such as superhigh molecular polyethylene or silicone to be used nor the sliding section members, impact load absorbing members or elastic deformation members of prostheses. The porous lamination components are, therefore, superior in enhancing the strength of the members made on organic materials and in joining the organic material members to bone tissues with which the organic material members make contact.
  • (Example 5)
  • Fig. 37 is a side view of an artificial vertebral body CE used as a prosthesis of the present invention. The main body CE1 of this artificial vertebral body is a cubic component made of alumina ceramics, measuring 10 x 10 x 5 mm. On the end surface thereof, a porous lamination component CE2 having a thickness of 1 mm and made of titanium is integrated with the main body CE1. The porous lamination component CE2 comprises ten laminated thin sheets, each having a thickness on 100 µm.
  • Fig. 38 is a top view of the artificial vertebral body CE used as a prosthesis of the present invention. The porous lamination component CE2 has most densely arranged through holes H with an effective diameter of 300 f..lm to form three-dimensional pores as shown in Fig. 39. At the almost central section of the end surface of the main body CE1, a joint-use cylinder CE3 measuring 0.98 mm in height and 2 mm in diameter is projecting. Around the internal circumference of the above-mentioned porous lamination component CE2, six deformation absorbing grooves CE4 are disposed so as to enclose the joint-use cylinder CE3. The pressure-fit surface CE5 making contact with the joint-use cylinder CE3 has a circular shape with a diameter of 2.3 mm. When each titanium thin sheet is placed on the end surface of the main body CE1, the pressure-fit surface CE5 functions to firmly make contact with the joint-use cylinder CE3.
  • Fig. 39 is a sectional view taken on line V-V of Fig. 38. The above-mentioned porous lamination component CE2 is supported and secured by the joint-use cylinder CE3 of the main body CE1. This assembly is then heated to about 900°C in the vacuum furnace so that the titanium thin sheets causes diffusion bonding. When paste including titanium particles is applied to the end surface of the above-mentioned main body CE1, the titanium particles combine with the metallic atoms of the porous lamination component CE2. In addition, the melted titanium on the thin sheets penetrates the small through holes disposed in the alumina ceramics of the main body CE1 at the end surface thereon to provide an anchoring effect. As a result, the joint between the porous lamination component CE2 and the main body CE1 is further enhanced.
  • The prosthesis of this example can be widely applied to the structures for surfaces making contact with bone tissues, such as femoral bone components of artificial knee joints made of ceramics, tibia components, iliac bone spacers, cranial bone prostheses and rib pins.
  • The prosthesis on the present invention can be firmly joined to living tissues by allowing the surrounding living tissues to promptly enclose the surfaces of the prosthesis after replacement and to penetrate the pores in the porous lamination component of the prosthesis and grow in the pores, thereby enhancing the durability of the prosthesis. Consequently, the present invention can provide prostheses which are not required to be replaced again, thereby imposing a less burden to patients.

Claims (6)

1. A prosthesis forthe replacement of hard tissues of human bones and joints comprising a porous lamination component of metal thin sheets, each having a plurality of through holes and a thickness of 150 f..lm or less, and being unharmful to the living body, said porous lamination component being formed such that said thin sheets are laid over one another and then diffusion-bonded therebetween into one body by heating so that said through holes communicate with one another in the direction of the thickness thereof.
2. A prosthesis for the replacement of hard tissues of human bones and joints according to claim 1, wherein the prosthesis is entirely composed of said porous lamination component.
3. A prosthesis for the replacement of hard tissues of human bones and joints according to claim 1, wherein the prosthesis is partially composed of said porous lamination component at a desired surface portion of the prosthesis base being made of metal, inorganic or organic material to fabricate artificial bones, joints or other prostheses.
4. A prosthesis for the replacement of hard tissues of human bones and joints according to any of claims 1 through 3, wherein said porous lamination component is covered at a desired surface portion thereof by a covering metal material being highly bio-compatible and corrosion-resistive in the living tissues or highly bonding-affinitive to other prostheses.
5. A method of making a prosthesis for the replacement of hard tissues of human bones and joints comprising the following steps of:
perforating metal thin sheets, each having a thickness of 150 µm or less to provide a plurality of through holes, and being unharmful to the living body;
laying said metal thin sheets thus obtained over one another so that said through holes may communicate with one another in the direction of the thickness thereof; and
diffusion-bonding between said metal thin sheets into one body by heating so as to form a porous lamination component for the prosthesis.
6. A method of making a prosthesis forthe replacement of hard tissues of human bones and joints according to claim 5, wherein said laminating and diffusion-bonding are taken place at a desired surface portion of the base of the prosthesis of an artificial bone or joint.
EP93302969A 1992-04-17 1993-04-16 A prothesis and a method of making the same Expired - Lifetime EP0566427B1 (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
JP9828292 1992-04-17
JP9828292 1992-04-17
JP98282/92 1992-04-17
JP09165493A JP3544550B2 (en) 1992-04-17 1993-04-19 Artificial prosthesis member and method of manufacturing the same

Publications (3)

Publication Number Publication Date
EP0566427A2 true EP0566427A2 (en) 1993-10-20
EP0566427A3 EP0566427A3 (en) 1994-06-15
EP0566427B1 EP0566427B1 (en) 2000-03-15

Family

ID=26433092

Family Applications (2)

Application Number Title Priority Date Filing Date
EP93302969A Expired - Lifetime EP0566427B1 (en) 1992-04-17 1993-04-16 A prothesis and a method of making the same
EP93305669A Expired - Lifetime EP0621018B1 (en) 1992-04-17 1993-07-19 A prosthesis and a method of making the same

Family Applications After (1)

Application Number Title Priority Date Filing Date
EP93305669A Expired - Lifetime EP0621018B1 (en) 1992-04-17 1993-07-19 A prosthesis and a method of making the same

Country Status (2)

Country Link
EP (2) EP0566427B1 (en)
JP (1) JP3544550B2 (en)

Cited By (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0647439A2 (en) * 1991-01-30 1995-04-12 Interpore International Porous articles and methods for producing same
EP0668062A1 (en) * 1994-02-18 1995-08-23 JOHNSON & JOHNSON PROFESSIONAL Inc. Bone prostheses with direct cast macrotextured surface regions and method for manufacturing the same
EP0672395A1 (en) * 1994-02-18 1995-09-20 JOHNSON & JOHNSON PROFESSIONAL Inc. Implantable articles with as-cast macrotextured surface regions and method of manufacturing the same
WO1996010966A1 (en) * 1994-10-07 1996-04-18 Baxter International Inc. Porous microfabricated polymer membrane structures
EP0891754A2 (en) * 1997-07-18 1999-01-20 Implantech Medizintechnik Ges.m.b.H. Implant, especially joint prosthesis implant
EP0621018B1 (en) * 1992-04-17 1999-09-15 Kyocera Corporation A prosthesis and a method of making the same
WO2007066669A1 (en) * 2005-12-05 2007-06-14 Mitsubishi Materials Corporation Medical device and method of modifying the surface of medical device
CN101336115B (en) * 2005-12-05 2012-11-07 三菱麻铁里亚尔株式会社 Medical device and method of modifying the surface of medical device
US20130221558A1 (en) * 2010-08-31 2013-08-29 Hiroshi Isshiki Apparatus for manufacturing absorbent body and method for manufacturing air-permeable member

Families Citing this family (37)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3450920B2 (en) * 1994-12-26 2003-09-29 京セラ株式会社 Method for manufacturing bioprosthesis member
AT403002B (en) 1996-05-29 1997-10-27 Mke Metall Kunststoffwaren FILM OR MEMBRANE FOR COVERING BONE DEFECTS, METHOD FOR PRODUCING THE FILM AND NAIL FOR FIXING THE POSITION OF SUCH A FILM
DE19635307A1 (en) * 1996-09-01 1998-03-05 Copf Franz Prof Dr Med Hip joint prosthesis component with cage and supporting plate
DE19713011C2 (en) * 1997-03-27 1999-10-21 Friadent Gmbh Foil for medical technology
DE19721192C2 (en) * 1997-05-21 2000-07-13 Dusan Ristic Biocompatible barrier membrane
JPH11178913A (en) * 1997-12-22 1999-07-06 Kyocera Corp Organism prosthetic material
US5899939A (en) * 1998-01-21 1999-05-04 Osteotech, Inc. Bone-derived implant for load-supporting applications
KR100308549B1 (en) * 1999-04-08 2001-09-24 이진호 Preparation of biodegradable polymer scaffold with uniform 3-dimensional porosity for tissue engineering
GB2354459B (en) 1999-09-22 2001-11-28 Viostyle Ltd Filtering element for treating liquids, dusts and exhaust gases of internal combustion engines
CA2323252C (en) 2000-10-12 2007-12-11 Biorthex Inc. Artificial disc
US7799086B2 (en) 2002-04-25 2010-09-21 Zimmer Technology, Inc. Modular bone implant, tools, and method
WO2004089254A1 (en) * 2003-04-01 2004-10-21 Olympus Corporation Material for repairing biological tissues and process for producing the same
EP1648348B1 (en) * 2003-07-24 2015-06-17 Tecomet Inc. Assembled non-random foams
US20050100578A1 (en) * 2003-11-06 2005-05-12 Schmid Steven R. Bone and tissue scaffolding and method for producing same
WO2005072785A1 (en) * 2004-01-30 2005-08-11 Cam Implants B.V. Highly porous 3 dimensional biocompatible implant structure
JP4524776B2 (en) 2004-04-14 2010-08-18 晶彦 千葉 Method for producing porous body for living body
US8608805B2 (en) 2005-09-16 2013-12-17 Zimmer Gmbh Insert and shell of a joint ball receptacle
EP1787603A1 (en) 2005-11-18 2007-05-23 Zimmer GmbH Basis-platform for an artificial joint
WO2008026316A1 (en) * 2006-08-31 2008-03-06 Japan Science And Technology Agency Composite artificial bone
JP2009066387A (en) * 2007-03-15 2009-04-02 Osaka Titanium Technologies Co Ltd Composite material for living body and its manufacturing method
DE102007056993A1 (en) * 2007-11-27 2009-06-04 Kilian Kraus Bone-contacting implants
US10842645B2 (en) 2008-08-13 2020-11-24 Smed-Ta/Td, Llc Orthopaedic implant with porous structural member
US9616205B2 (en) 2008-08-13 2017-04-11 Smed-Ta/Td, Llc Drug delivery implants
EP2323587B1 (en) * 2008-08-13 2016-08-03 SMed - TA/TD LLC Drug delivery implants
US9700431B2 (en) 2008-08-13 2017-07-11 Smed-Ta/Td, Llc Orthopaedic implant with porous structural member
FR2949667B1 (en) * 2009-09-09 2011-08-19 Obl POROUS STRUCTURE WITH A CONTROLLED PATTERN, REPEAT IN SPACE, FOR THE PRODUCTION OF SURGICAL IMPLANTS
ES2532826T3 (en) * 2009-10-30 2015-04-01 DePuy Synthes Products, LLC Prosthesis with different texture surfaces
MX343149B (en) * 2010-07-23 2016-10-26 Privelop-Spine Ag * Surgical implant.
RU2477666C2 (en) * 2011-01-31 2013-03-20 Государственное образовательное учреждение высшего профессионального образования "Самарский государственный аэрокосмический университет имени академика С.П. Королева" (СГАУ) Method of making nonwoven wire materials for prostatic dentistry devices
US20140335370A1 (en) * 2011-11-24 2014-11-13 Kyocera Medical Corporation Biocompatible metallic porous plate
JP5965746B2 (en) 2012-06-29 2016-08-10 京セラメディカル株式会社 Artificial joint stem, artificial joint stem components, and artificial joint stem manufacturing method
GB2511825A (en) 2013-03-14 2014-09-17 Ostomycure As Implant
US9724203B2 (en) * 2013-03-15 2017-08-08 Smed-Ta/Td, Llc Porous tissue ingrowth structure
JP6464470B2 (en) * 2014-05-07 2019-02-06 帝人ナカシマメディカル株式会社 Implant and manufacturing method thereof
DE102015213846A1 (en) * 2014-07-22 2016-01-28 Ceramtec Gmbh Components for fusion of vertebral bodies
HK1224885A (en) * 2016-09-08 2017-08-25
RU178565U1 (en) * 2017-09-18 2018-04-11 Федеральное государственное бюджетное образовательное учреждение высшего образования "Самарский государственный медицинский университет" Министерства здравоохранения Российской Федерации Joint Endoprosthesis Element

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2215927A1 (en) * 1973-01-31 1974-08-30 Louyot Comptoir Lyon Alemand
GB2142544A (en) * 1983-07-04 1985-01-23 Oec Orthopaedic Limited Surgical implant
WO1986003671A1 (en) * 1984-12-14 1986-07-03 Klaus Draenert Bone replacement material and utilization thereof
US4636219A (en) * 1985-12-05 1987-01-13 Techmedica, Inc. Prosthesis device fabrication
DE3918967A1 (en) * 1988-06-10 1989-12-21 Haruyuki Kawahara FRAMELESS AND CORELESS POROESES ENOSSAL IMPLANT

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4570271A (en) * 1981-07-27 1986-02-18 Battelle Development Corporation Porous coatings from wire mesh for bone implants
JPS63119749A (en) * 1985-11-27 1988-05-24 川原 春幸 Dental implant having multiple capillary structure
DE3715000A1 (en) * 1987-05-06 1988-11-17 Krupp Gmbh JOINT PROSTHESIS AND METHOD FOR THEIR PRODUCTION
JPH0349766A (en) * 1989-07-18 1991-03-04 Kawasaki Steel Corp Production of porous body having excellent osteoaffinity
DE9011363U1 (en) * 1989-09-28 1990-11-15 Pfizer Hospital Products Group, Inc., New York, N.Y., Us
US5112354A (en) * 1989-11-16 1992-05-12 Northwestern University Bone allograft material and method
EP0566427B1 (en) * 1992-04-17 2000-03-15 Kyocera Corporation A prothesis and a method of making the same

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2215927A1 (en) * 1973-01-31 1974-08-30 Louyot Comptoir Lyon Alemand
GB2142544A (en) * 1983-07-04 1985-01-23 Oec Orthopaedic Limited Surgical implant
WO1986003671A1 (en) * 1984-12-14 1986-07-03 Klaus Draenert Bone replacement material and utilization thereof
US4636219A (en) * 1985-12-05 1987-01-13 Techmedica, Inc. Prosthesis device fabrication
DE3918967A1 (en) * 1988-06-10 1989-12-21 Haruyuki Kawahara FRAMELESS AND CORELESS POROESES ENOSSAL IMPLANT

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
JOURNAL OF BIOMEDICAL MATERIAL RESEARCH vol. 19, no. 6 , June 1985 , NEW YORK pages 685 - 698 NAKAMURA ET AL. 'A new glass-ceramic for bone replacement: Evaluation of its bonding to bone tissue' *

Cited By (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0647439A2 (en) * 1991-01-30 1995-04-12 Interpore International Porous articles and methods for producing same
EP0647439A3 (en) * 1991-01-30 1997-04-23 Interpore International Porous articles and methods for producing same.
EP0621018B1 (en) * 1992-04-17 1999-09-15 Kyocera Corporation A prosthesis and a method of making the same
EP0668062A1 (en) * 1994-02-18 1995-08-23 JOHNSON & JOHNSON PROFESSIONAL Inc. Bone prostheses with direct cast macrotextured surface regions and method for manufacturing the same
EP0672395A1 (en) * 1994-02-18 1995-09-20 JOHNSON & JOHNSON PROFESSIONAL Inc. Implantable articles with as-cast macrotextured surface regions and method of manufacturing the same
US5665118A (en) * 1994-02-18 1997-09-09 Johnson & Johnson Professional, Inc. Bone prostheses with direct cast macrotextured surface regions and method for manufacturing the same
US5713410A (en) * 1994-02-18 1998-02-03 Johnson & Johnson Professional, Inc. Bone prostheses with direct cast macrotextured surface regions and method for manufacturing the same
WO1996010966A1 (en) * 1994-10-07 1996-04-18 Baxter International Inc. Porous microfabricated polymer membrane structures
US5807406A (en) * 1994-10-07 1998-09-15 Baxter International Inc. Porous microfabricated polymer membrane structures
AT405236B (en) * 1997-07-18 1999-06-25 Implantech Medizintechnik Ges IMPLANT, IN PARTICULAR JOINT PROSTHESIS IMPLANT
EP0891754A3 (en) * 1997-07-18 1999-03-03 Implantech Medizintechnik Ges.m.b.H. Implant, especially joint prosthesis implant
EP0891754A2 (en) * 1997-07-18 1999-01-20 Implantech Medizintechnik Ges.m.b.H. Implant, especially joint prosthesis implant
WO2007066669A1 (en) * 2005-12-05 2007-06-14 Mitsubishi Materials Corporation Medical device and method of modifying the surface of medical device
EP1958650A1 (en) * 2005-12-05 2008-08-20 Mitsubishi Materials Corporation Medical device and method of modifying the surface of medical device
US20090162235A1 (en) * 2005-12-05 2009-06-25 Mitsubishi Materials Corporation Medical device and surface modification method for medical device
EP1958650A4 (en) * 2005-12-05 2012-05-30 Mitsubishi Materials Corp Medical device and method of modifying the surface of medical device
CN101336115B (en) * 2005-12-05 2012-11-07 三菱麻铁里亚尔株式会社 Medical device and method of modifying the surface of medical device
US9138301B2 (en) 2005-12-05 2015-09-22 Mitsubishi Materials Corporation Medical device and surface modification method for medical device
US20130221558A1 (en) * 2010-08-31 2013-08-29 Hiroshi Isshiki Apparatus for manufacturing absorbent body and method for manufacturing air-permeable member
US9486946B2 (en) * 2010-08-31 2016-11-08 Uni-Charm Corporation Apparatus for manufacturing absorbent body and method for manufacturing air-permeable member

Also Published As

Publication number Publication date
EP0566427B1 (en) 2000-03-15
JP3544550B2 (en) 2004-07-21
JPH067388A (en) 1994-01-18
EP0621018A1 (en) 1994-10-26
EP0566427A3 (en) 1994-06-15
EP0621018B1 (en) 1999-09-15

Similar Documents

Publication Publication Date Title
EP0621018B1 (en) A prosthesis and a method of making the same
US5732469A (en) Prosthesis and a method of making the same
AU645085B2 (en) Porous fixation surface
US7208222B2 (en) Assembled non-random foams
US6087553A (en) Implantable metallic open-celled lattice/polyethylene composite material and devices
CN107847327B (en) Porous structure for bone implant
US8043382B2 (en) Reinforced medical implants
KR101736751B1 (en) A medical implant device
EP3058896A1 (en) Prosthesis
EP3845204B1 (en) Metal and ceramic composite joint prosthesis, and application thereof and manufacturing method therefor
WO2013181141A1 (en) Anisotropic porous scaffols and method of making anisotropic porous scaffolds
EP3409241B1 (en) Customizable augments for acetabular implants
CA2664560A1 (en) Medical implant
WO2004021934A2 (en) A cup assembly of an orthopaedic joint prosthesis
US10687947B2 (en) Augments and methods for implanting hip prostheses
JPH1147171A (en) Artificial prosthetic member
JP3214969B2 (en) Prosthetic components
JPH04166148A (en) Bioprosthetic member

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

AK Designated contracting states

Kind code of ref document: A2

Designated state(s): DE FR IT

PUAL Search report despatched

Free format text: ORIGINAL CODE: 0009013

AK Designated contracting states

Kind code of ref document: A3

Designated state(s): DE FR IT

17P Request for examination filed

Effective date: 19941213

17Q First examination report despatched

Effective date: 19961209

GRAG Despatch of communication of intention to grant

Free format text: ORIGINAL CODE: EPIDOS AGRA

GRAG Despatch of communication of intention to grant

Free format text: ORIGINAL CODE: EPIDOS AGRA

GRAH Despatch of communication of intention to grant a patent

Free format text: ORIGINAL CODE: EPIDOS IGRA

GRAH Despatch of communication of intention to grant a patent

Free format text: ORIGINAL CODE: EPIDOS IGRA

GRAA (expected) grant

Free format text: ORIGINAL CODE: 0009210

AK Designated contracting states

Kind code of ref document: B1

Designated state(s): DE FR IT

ITF It: translation for a ep patent filed

Owner name: BUZZI, NOTARO&ANTONIELLI D'OULX

REF Corresponds to:

Ref document number: 69328047

Country of ref document: DE

Date of ref document: 20000420

ET Fr: translation filed
PLBE No opposition filed within time limit

Free format text: ORIGINAL CODE: 0009261

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: NO OPPOSITION FILED WITHIN TIME LIMIT

26N No opposition filed
PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: DE

Payment date: 20120425

Year of fee payment: 20

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: FR

Payment date: 20120504

Year of fee payment: 20

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: IT

Payment date: 20120418

Year of fee payment: 20

REG Reference to a national code

Ref country code: DE

Ref legal event code: R071

Ref document number: 69328047

Country of ref document: DE

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: DE

Free format text: LAPSE BECAUSE OF EXPIRATION OF PROTECTION

Effective date: 20130417